{"study_id": 7149, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of a dietary supplement containing Chondroitin Sulfate, in combination with other ingredients, in reducing recurrent urinary tract infection (rUTI) episodes and improving quality of life.", "results_summary": "The combination therapy (fosfomycin and the dietary supplement) showed the greatest reduction in rUTI episodes and significant improvement in quality of life compared to monotherapy with either fosfomycin or the supplement alone. Chondroitin was part of the supplement blend, but its individual effects were not isolated in the results.", "population_specificity": "Women aged 21-65 with a history of recurrent UTIs.", "effective_dosage": "Not specified for Chondroitin individually.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:20:55.927609+00:00"}
{"study_id": 7156, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and therapeutic efficacy of a chondroitin sulfate-based hydrogel cryo-microneedle patch for delivering melittin to treat rheumatoid arthritis.", "results_summary": "The study found that the chondroitin sulfate-melittin complex (MC) effectively mitigated melittin's acute toxicity, induced apoptosis in fibroblast-like synoviocytes, and significantly reduced joint damage and arthritis severity in a rat model of rheumatoid arthritis.", "population_specificity": "RA rat model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:20:55.993822+00:00"}
{"study_id": 7150, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop an Imatinib-loaded nanoparticle delivery system using a chondroitin sulfate derivative to enhance targeting efficiency for activated hepatic stellate cells (aHSCs) and improve therapeutic effects for hepatic fibrosis.", "results_summary": "The study found that chondroitin sulfate-modified nanoparticles (IM-CS NPs) exhibited better targeting ability for aHSCs, leading to significant fibrosis resolution in mouse models, along with excellent biocompatibility and safety.", "population_specificity": "Carbon tetrachloride-induced hepatic fibrosis mouse models.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:20:56.129827+00:00"}
{"study_id": 7155, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a stable embedding strategy for anthocyanins (ACNs) using chondroitin sulfate (CS) and whey protein isolate (WPI) to enhance their physicochemical stability and bioactivity.", "results_summary": "The CS/WPI@ACN complex achieved high encapsulation efficiency (84.87%), demonstrated stability under harsh conditions, enabled sustained ACN release in the gastrointestinal tract, and showed higher antioxidant activity compared to free ACN.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "CS-to-WPI mass ratio of 1:5, core-to-wall material ratio of 1:3", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:20:56.836168+00:00"}
{"study_id": 7157, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of a novel rosmarinic acid-chondroitin sulfate A (RA-CSA) nanoconjugate for treating ulcerative colitis in a mouse model.", "results_summary": "RA-CSA nanoassemblies demonstrated significant antioxidant and anti-inflammatory effects, reduced colonic inflammation, and suppressed pro-inflammatory cytokines in DSS-induced colitis mice, outperforming parent RA.", "population_specificity": "DSS-induced acute colitis mouse model.", "effective_dosage": "200 \u03bcg mL-1 (in vitro); oral administration dosage not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:02.617533+00:00"}
{"study_id": 7158, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the potential of a chondroitin sulfate methacrylate-based drug delivery system (CM@pGM) for treating osteoarthritis by improving the inflammatory microenvironment and promoting cartilage repair.", "results_summary": "The study found that CM@pGM microspheres significantly reduced osteophyte formation, alleviated degenerative changes in articular cartilage, and delayed OA progression, with sustained drug release over 2 weeks. The release of GA, Mg2+, and PA improved the inflammatory microenvironment and mitigated oxidative stress.", "population_specificity": "Osteoarthritis (OA) model (in vitro and in vivo, specific human population not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified (in vitro release period extended over 2 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:03.831250+00:00"}
{"study_id": 7163, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and characterize lyophilized chondroitin sulfate-loaded solid lipid nanoparticles (SLNs) for advanced drug delivery, focusing on stability, encapsulation efficiency, and therapeutic potential.", "results_summary": "The study found that CHON-loaded SLNs, particularly SLN-2, demonstrated high encapsulation efficiency (\u226588%) and stability, with minimal excipient interactions, making them promising for sustained-release therapies in inflammatory and degenerative diseases.", "population_specificity": "Not specified (in vitro/animal study implied by methods).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:04.160249+00:00"}
{"study_id": 7159, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a paclitaxel nanocrystal delivery platform using chondroitin sulfate modified with 3-indoleacetic acid (CS-IAA) to enhance tumor targeting and therapeutic efficacy in pancreatic cancer.", "results_summary": "PTX@CS-IAA nanocrystals demonstrated high drug loading (46.6%), improved tumor targeting via CD44 receptors, increased ROS levels at tumor sites, and significantly enhanced antitumor effects in an orthotopic pancreatic cancer mouse model, especially when combined with \u03b1PD-L1 antibody.", "population_specificity": "Orthotopic pancreatic cancer mouse model.", "effective_dosage": "Not specified (high drug loading of 46.6% mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:04.286563+00:00"}
{"study_id": 7164, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of a dissolvable microneedle system containing chondroitin sulfate (CS) for delivering a combination of photothermal and chemotherapeutic agents to treat melanoma.", "results_summary": "The study found that the CS-based microneedle system effectively delivered the therapeutic agents, resulting in significant inhibition of melanoma through photothermal and chemotherapeutic synergy, including disruption of blood vessels, apoptosis induction, and mitochondrial membrane potential alteration.", "population_specificity": "Subcutaneous melanoma (A375) model in nude mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:04.738409+00:00"}
{"study_id": 7162, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of Teriflunomide-loaded chondroitin sulfate hybridized zein nanoparticles (TZCNPs) for treating triple-negative breast cancer (TNBC).", "results_summary": "TZCNPs showed significantly enhanced cytotoxicity, apoptosis, and tumor spheroid disintegration compared to free Teriflunomide, with improved pharmacokinetic properties and a good safety profile. The study strongly indicated CD44-mediated uptake as a critical mechanism for TZCNPs' efficacy.", "population_specificity": "Triple-negative breast cancer (TNBC) cells (MDA-MB-231 and MCF-7).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:05.303399+00:00"}
{"study_id": 7161, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop nanogels composed of chondroitin sulfate and chitosan for targeted delivery of naringenin-\u03b2-cyclodextrin complex to treat early-stage diabetic retinopathy.", "results_summary": "The study found that optimized nanogel formulations (N3 and N9) showed favorable characteristics for cellular uptake, enhanced drug solubility, sustained release, and antioxidant properties, suggesting potential efficacy for retinal endothelial targeting.", "population_specificity": "Human Umbilical Vein Endothelial Cells (HUVEC) in vitro; future studies planned on diabetic animal models.", "effective_dosage": "0.5 mg/mL polymer concentration (specific chondroitin dosage not detailed).", "study_duration": "In vitro release tested over 72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:05.349061+00:00"}
{"study_id": 7165, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop chondroitin sulfate microspheres (CMs) capable of delivering both idarubicin (Ida) and Lenvatinib (Len) to achieve a triple therapeutic effect on liver cancer: embolic starvation, drug toxicity, and inhibition of neovascularization.", "results_summary": "The study found that chondroitin sulfate microspheres could encapsulate both cytotoxic and vascular inhibitor drugs, potentially enhancing the efficacy of TACE by addressing revascularization and drug delivery limitations. The approach showed promise for a combined therapeutic effect on liver cancer.", "population_specificity": "Patients with intermediate-to-advanced hepatocellular carcinoma (HCC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:05.922578+00:00"}
{"study_id": 7166, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential anti-obesity effects of chondroitin sulfate (CS) in high-fat diet-induced obese mice, focusing on weight control, fat accumulation, and gut microbiota modulation.", "results_summary": "CS supplementation effectively reduced body weight gain, fat accumulation, and serum glucose and triglyceride levels in obese mice. It also altered gut microbiota composition, decreasing Desulfobacterota and increasing Bacteroides abundance, suggesting a potential role in obesity mitigation.", "population_specificity": "High-fat diet-induced obese mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:11.201997+00:00"}
{"study_id": 7168, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a nanoparticle (LCF-CSBN) containing chondroitin sulfate could selectively reprogram lipid metabolism in macrophages to reduce inflammation and cartilage degeneration in osteoarthritis.", "results_summary": "LCF-CSBN effectively promoted M1 to M2 macrophage transition, attenuated joint inflammation, oxidative stress, and cartilage degeneration in OA model rats, and remained in the joint for up to 28 days.", "population_specificity": "OA model rats", "effective_dosage": "Not specified", "study_duration": "Up to 28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:12.202502+00:00"}
{"study_id": 7169, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory and protective effects of chondroitin sulfate (CS) and glucosamine (GlcN) in a rat model of ulcerative colitis induced by dextran sulfate sodium (DSS).", "results_summary": "The study found that oral administration of CS/GlcN reduced the severity of acute colitis, improved histological scores, decreased goblet cell destruction, and lowered NO production, myeloperoxidase, and MMP-9 activities. The combination was non-cytotoxic to intestinal epithelial cells, suggesting potential benefits for inflammatory bowel disease (IBD) treatment.", "population_specificity": "Rats with DSS-induced ulcerative colitis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:13.508678+00:00"}
{"study_id": 7170, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the synergistic effects of Chondroitin sulfate (CS) and liposomes derived from salmon co-products on combating inflammation in human chondrocytes.", "results_summary": "The study found that CS, in synergy with liposomes, effectively reduced inflammation markers and collagenase production in human chondrocytes under inflamed conditions, even at low concentrations.", "population_specificity": "Human chondrocytes in inflamed conditions (in vitro study).", "effective_dosage": "Two different concentrations (specific amounts not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:13.524613+00:00"}
{"study_id": 7172, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the therapeutic effects and molecular mechanisms of chondroitin sulfate (CS) on inflammation and cartilage degradation in feline and canine articular chondrocytes.", "results_summary": "CS treatment significantly enhanced cell viability, reduced oxidative stress, suppressed pro-inflammatory cytokines, and reduced apoptosis in chondrocytes. Transcriptomic and metabolomic analyses indicated CS upregulated pathways promoting cell survival and energy metabolism while downregulating inflammatory mediators.", "population_specificity": "Feline and canine articular chondrocytes (in vitro study).", "effective_dosage": "800\u202f\u00b5g/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:13.859119+00:00"}
{"study_id": 7167, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether sequential intravesical instillations of combined hyaluronic acid and chondroitin sulfate could reduce local BCG toxicity and urinary symptoms in patients with non-muscle-invasive bladder cancer.", "results_summary": "The study found that adding HA + CS significantly reduced storage symptoms, pelvic pain, and daytime urinary frequency in patients with BCG-induced chemical cystitis, with no reported local or major side effects. Group A (HA + CS) showed sustained improvement in irritative lower urinary symptoms over 6 months, unlike the control group.", "population_specificity": "Patients with intermediate- and high-risk non-muscle-invasive bladder cancer who underwent BCG intravesical administration after tumor resection.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6-month follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:14.411671+00:00"}
{"study_id": 7173, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify the main targets of fucosylated chondroitin sulfate (FCS) in inhibiting lung adenocarcinoma (LUAD) cell proliferation and assess its potential to enhance cisplatin sensitivity.", "results_summary": "FCS inhibited LUAD A549 cell growth and increased cisplatin sensitivity by down-regulating BUB1 and PLK1 mRNA expression, with combined FCS and cisplatin treatment showing more significant effects than either treatment alone.", "population_specificity": "Lung adenocarcinoma (LUAD) A549 cells in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:14.559497+00:00"}
{"study_id": 7171, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of chondroitin sulfate-stabilized gold nanoparticles (CS-Au NPs) in selectively targeting and inducing apoptosis in human osteosarcoma cells (MG63) while sparing normal cells (NIH3T3).", "results_summary": "CS-Au NPs significantly reduced viability in MG63 cells at 100 \u03bcg/mL, increased reactive oxygen species (ROS) production, and induced apoptosis, while showing no cytotoxicity in NIH3T3 cells at the same concentration.", "population_specificity": "Human osteosarcoma cells (MG63) and mouse embryonic fibroblast cells (NIH3T3).", "effective_dosage": "100 \u03bcg/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:14.835087+00:00"}
{"study_id": 7174, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Chondroitin sulfate (CHDS) as a biomaterial for cancer-targeted drug delivery systems, focusing on its biological properties and therapeutic applications.", "results_summary": "The study highlights CHDS's biocompatibility, biodegradability, and low toxicity, positioning it as a promising candidate for enhancing cancer treatment efficacy and minimizing side effects in drug delivery platforms.", "population_specificity": "Not specified (general cancer therapy context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:22.195682+00:00"}
{"study_id": 7176, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a CD44-targeted, ROS-responsive chondroitin sulfate-bilirubin conjugate (CS-BR) could effectively treat acute kidney injury by targeting inflammation, oxidative stress, and mitochondrial dysfunction.", "results_summary": "CS-BR@CLT selectively accumulated in injured kidneys, reduced apoptosis, protected mitochondria, promoted autophagy, regulated macrophage polarization, and alleviated inflammation, significantly improving renal function in AKI mice.", "population_specificity": "AKI mouse model (ischemia-reperfusion injury)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:22.790793+00:00"}
{"study_id": 7179, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a mass spectrometry imaging (MSI) approach to detect, identify, localize, and profile chondroitin and other GAG oligosaccharides directly from retinal tissue.", "results_summary": "The study successfully demonstrated a method to spatially resolve chondroitin, dermatan, and hyaluronan oligosaccharides from disaccharides to hexasaccharides in retinal tissue, enabling the separation of isomeric GAG oligosaccharide ions at histologically relevant regions.", "population_specificity": "Retinal tissue (not human subjects).", "effective_dosage": "Not available.", "study_duration": "Not applicable (methodological study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:23.722265+00:00"}
{"study_id": 7178, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a crosslinked hydrogel composed of chondroitin sulfate lithium (CS-Li) could promote bone regeneration in a diabetic environment by regulating macrophage polarization and enhancing angiogenesis and osteogenesis.", "results_summary": "The study found that the CS-Li hydrogel exhibited excellent biocompatibility, osteogenesis properties, and the ability to regulate macrophage polarization to an anti-inflammatory phenotype, alleviating diabetes-induced inhibition of angiogenesis and osteogenesis both in vitro and in vivo. The effects were attributed to the activation of Glycogen synthase kinase-3\u03b2/\u03b2-catenin pathways.", "population_specificity": "Diabetic patients with bone defects (studied in vitro and in vivo models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:24.283147+00:00"}
{"study_id": 7181, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a chondroitin sulfate-functionalized nanozyme (CS-Lip/PB@Rap) could target inflammatory macrophages and VSMCs in atherosclerosis, modulate oxidative stress, and inhibit inflammatory cascades.", "results_summary": "The study found that CS-Lip/PB@Rap effectively targeted CD44 receptors, restored oxidative balance, inhibited NF-\u03baB pathway activation, and reduced inflammatory macrophage production and VSMC phenotype transformation, thereby alleviating atherogenic progression.", "population_specificity": "Inflammatory macrophages and vascular smooth muscle cells in an atherosclerotic plaque model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:24.286619+00:00"}
{"study_id": 7175, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of chondroitin sulfate proteoglycan-4 (CSPG4) in dysregulated neuro-cardiac communication in DMD and assess the effects of Givinostat on restoring cardiac function and reducing CSPG4 content.", "results_summary": "The study found that CSPG4 over-release by macrophages in dystrophic cardiac tissue contributes to neuro-cardiac dysfunction in DMD. Givinostat reduced CSPG4 levels, improved cardiac function, and decreased inflammation and fibrosis in mdx mice.", "population_specificity": "Mouse model of Duchenne muscular dystrophy (mdx mice).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:24.295213+00:00"}
{"study_id": 7177, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether the combination of quercetin and chondroitin sulfate could reduce oxidative stress, inflammation, and microbial-induced exacerbations in rheumatoid arthritis.", "results_summary": "The study found that the quercetin-chondroitin sulfate combination significantly inhibited oxidative stress and hemolysis, demonstrated strong antioxidant and antimicrobial effects, and reduced pro-inflammatory markers in vivo. It also improved survival rates and joint health in zebrafish subjected to bacterial stress.", "population_specificity": "Zebrafish subjected to bacterial stress (in vivo) and in vitro assays.", "effective_dosage": "1:1 ratio (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:26.093824+00:00"}
{"study_id": 7180, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the cost-effectiveness of pharmaceutical-grade chondroitin sulfate (CS) compared to placebo in managing symptomatic knee osteoarthritis (OA) from a European perspective.", "results_summary": "CS demonstrated cost-effectiveness compared to placebo, with a mean incremental cost-effectiveness ratio (ICER) of 33,462 EUR per QALY gained and a 93% probability of being cost-effective at the predefined threshold. The treatment also showed superior pain reduction and functional improvement over 6 months.", "population_specificity": "Patients with symptomatic knee osteoarthritis.", "effective_dosage": "800 mg/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:26.239651+00:00"}
{"study_id": 7182, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the impact of different fucosylated chondroitin sulfate (FCS) derivatives on nutrient absorption, growth promotion, and metabolic homeostasis in mice.", "results_summary": "The study found that FCS derivatives positively correlated with increased weight gain and enhanced nutrient absorption in mice, with higher branching and larger molecular weight FCS exhibiting greater biological activity. Short-chain fatty acid levels in plasma and feces suggested FCS may facilitate gastrointestinal catabolic activities.", "population_specificity": "75 mice (225 plasma and feces samples analyzed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:30.829924+00:00"}
{"study_id": 7183, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of chondroitin sulfate-selenium nanoparticles (CS@Se) on cognitive function, neuronal structure, and gut microbiota in Alzheimer's disease (AD) mice.", "results_summary": "CS@Se improved spatial learning, memory, and anxiety in AD mice, reduced hippocampal neuron damage, enhanced mitochondrial health, and restored gut flora balance by increasing Firmicutes and Actinobacteria while decreasing Bacteroidetes and Proteobacteria.", "population_specificity": "Male C57BL/6J mice with induced Alzheimer's disease.", "effective_dosage": "Not specified.", "study_duration": "40 days of intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:31.996087+00:00"}
{"study_id": 7184, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potential of chondroitin sulphate-based nanomicelles (BBR/CS-DOX) to enhance breast cancer treatment by inhibiting cancer-associated fibroblasts (CAFs) and tumor cell crosstalk in the tumor microenvironment.", "results_summary": "The study found that BBR/CS-DOX improved drug absorption and retention, demonstrated stronger pro-apoptotic and anti-metastatic effects compared to free drugs, and effectively prevented fibroblast activation, ECM deposition, and tumor angiogenesis.", "population_specificity": "Breast cancer models (MCF-7 + MRC-5 co-cultured cells and 4T1 + NIH3T3 co-implanted mice).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:33.400863+00:00"}
{"study_id": 7185, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential of CSPG4 (Chondroitin sulfate proteoglycan 4) as a target for immunotherapy in melanoma and summarize current immunotherapeutic strategies against CSPG4-expressing melanomas.", "results_summary": "The study found that CSPG4 is overexpressed in human melanoma and involved in cancer-promoting pathways, making it a promising target for immunotherapies such as monoclonal antibodies, ADCs, and CAR T cells. Several preclinical models showed promising results, but clinical testing and approval remain limited due to gaps in understanding CSPG4 function and lack of representative in vivo models.", "population_specificity": "Human melanoma patients and preclinical models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:33.899675+00:00"}
{"study_id": 7186, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Chondroitin Sulfate (CS) methacrylated hydrogels could serve as a safe and effective local delivery system for dinutuximab to improve anti-tumoral response in high-risk neuroblastoma.", "results_summary": "The study found that intratumoral delivery of dinutuximab-loaded CSMA hydrogels significantly slowed tumor growth compared to systemic administration, with 4-hour reacted 10% CSMA hydrogels showing the highest dinutuximab release. The CSMA hydrogel alone also slowed tumor growth, suggesting potential interactions with tumor microenvironment components.", "population_specificity": "Orthotopic mouse model of high-risk neuroblastoma.", "effective_dosage": "10% and 20% CSMA hydrogels.", "study_duration": "24-day in vitro release study; in vivo tumor growth monitored until specific size was reached.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:35.012624+00:00"}
{"study_id": 7188, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether multifunctional microspheres integrating Prussian blue nanozymes and vascular endothelial growth factor, coated with dopamine, could improve wound healing by reducing oxidative stress, inflammation, and promoting angiogenesis.", "results_summary": "The microspheres adhered well to the wound surface, effectively scavenged ROS, reduced inflammatory response, and promoted angiogenesis, leading to improved wound healing. The integration of nanozymes and growth factors demonstrated a synergistic effect.", "population_specificity": "Not specified (in vitro or animal model implied by the abstract).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:35.104576+00:00"}
{"study_id": 7187, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to compare the effects of microfracture (MF) alone versus MF combined with hyaluronic acid (HA) and oral glucosamine and chondroitin sulfate (GC) in patients with osteoarthritic knees after medial open wedge high tibial osteotomy (MOWHTO).", "results_summary": "The study found that MF alone was sufficient to improve clinical outcomes, with no significant additional benefit from HA + GC. Groups receiving MF (with or without HA + GC) showed better KOOS and VAS scores than the group receiving only HTO, but there was no significant difference between the MF and MF + HA + GC groups.", "population_specificity": "Patients with osteoarthritic knees who underwent MOWHTO due to gonarthrosis.", "effective_dosage": "Not specified", "study_duration": "Average follow-up of five years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:35.324422+00:00"}
{"study_id": 7189, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 78, "quality_score": 82, "study_goal": "The researchers aimed to optimize a solid lipid nanoparticle (SLN) formulation to enhance chondroitin sulfate (CHON) permeation for osteoarthritis (OA) therapy.", "results_summary": "The study successfully optimized SLN formulation for efficient CHON transport through pig ear skin, demonstrating improved skin permeation and retention with no cellular toxicity. The nanoparticles showed successful internalization and were confirmed as effective CHON carriers.", "population_specificity": "Pig ear skin (in vitro/ex vivo model)", "effective_dosage": "0.4 mg/mL CHON concentration", "study_duration": "Not specified (acute exposure in lab settings)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:36.196214+00:00"}
{"study_id": 7191, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to develop and evaluate an injectable chondroitin sulfate complex hydrogel (C-A hydrogel) for preventing postoperative adhesions.", "results_summary": "The C-A hydrogel demonstrated enhanced mechanical strength, self-healing ability, and biocompatibility, effectively reducing postoperative adhesions in rat models (cecal-abdominal wall and hepatic adhesion models).", "population_specificity": "Rat models (cecal-abdominal wall and hepatic adhesion models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:39.867034+00:00"}
{"study_id": 7190, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the impact of chondroitin sulfate (CHS) from Halaelurus burgeri skin on endoplasmic reticulum (ER) stress, inflammation, and gut microbiota in high-fat diet-fed mice.", "results_summary": "CHS reduced ER stress, lowered blood glucose, NO, ROS, and FFA levels, increased hepatic glycogen, improved inflammation via TLR4/JNK/NF\u03baB pathway inhibition, and regulated gut microbiota by reducing the Firmicutes/Bacteroidetes ratio and altering fecal metabolites.", "population_specificity": "High-fat diet-fed C57BL/6J mice", "effective_dosage": "Not specified", "study_duration": "18 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:40.115742+00:00"}
{"study_id": 7192, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and evaluate ECINs, a novel nanomedicine using chondroitin sulfate A (CSA) derivatives, to improve tumor targeting and antitumor efficacy of erastin while minimizing off-target toxicity.", "results_summary": "ECINs demonstrated enhanced tumor distribution of erastin, reduced off-target accumulation, and significantly decreased tumor size when combined with laser irradiation, with minimal systemic toxicity. The study showed a non-ferroptotic mechanism of cancer cell inhibition via G1-phase cell cycle arrest.", "population_specificity": "SK-HEP-1 xenograft mice (liver cancer model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:43.021140+00:00"}
{"study_id": 7194, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a novel CH-CS-DZ nanoconjugate in treating glucocorticoid-induced osteoporosis in a zebrafish model.", "results_summary": "The CH-CS-DZ nanoconjugate significantly reduced oxidative stress and apoptosis, improved survival and hatching rates, restored bone mineralization, and modulated gene expression related to osteoporosis.", "population_specificity": "Zebrafish larvae", "effective_dosage": "3% DZ concentration in the nanoconjugate", "study_duration": "96 hours (drug release study); intervention duration not explicitly stated", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:43.540606+00:00"}
{"study_id": 7193, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a combination of chondroitin sulfate and Lactiplantibacillus plantarum CCFM8661 could reduce lead (Pb) accumulation and mitigate Pb-induced damage in tissues, gut microbiota, and fecal metabolites in Pb-exposed mice.", "results_summary": "The combination reduced Pb accumulation in liver, kidney, and bone tissues, improved antioxidant capacity, restored gut microbiota balance, and altered fecal metabolites linked to purine and amino acid metabolism.", "population_specificity": "Pb-exposed mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:44.112355+00:00"}
{"study_id": 7195, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of chondroitin sulfate oligosaccharides (oligo-CS) against osteoarthritis (OA) by targeting NLRP3 inflammation.", "results_summary": "Oligo-CS treatment significantly reduced inflammation, inhibited NLRP3 inflammasome activation, and maintained cartilage integrity in both in vitro and in vivo models. It also improved gut microbiota composition in mice.", "population_specificity": "Human SW1353 chondrocytes, human mononuclear macrophage THP-1 cells, and C57BL/6 female mice.", "effective_dosage": "Not specified", "study_duration": "28 days (in vivo)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:44.555344+00:00"}
{"study_id": 7197, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop an improved Fenton-like system for degrading chondroitin sulfate (CS) while preserving its structural integrity and evaluating its potential antioxidant and anti-CRISPR activity.", "results_summary": "The study found that the tri-CN system effectively degraded CS without significant desulfurization, producing structurally intact products with promising antioxidant and anti-CRISPR potential. The high-valent iron species in the material catalyzed the cleavage of hydrogen peroxide, generating hydroxyl radicals that fragmented CS chains.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:44.574926+00:00"}
{"study_id": 7196, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the association between treatment types (including hyaluronic acid-chondroitin sulphate [HA-CS] in combination with antimuscarinic or alone) and functional outcomes in patients with overactive bladder (OAB).", "results_summary": "The combination of HA-CS with antimuscarinic showed a significant reduction in micturitions and urgency, as well as lower rates of pelvic pain. However, no significant improvements were observed for incontinence or nocturia in antimuscarinic drop-out patients treated with HA-CS alone.", "population_specificity": "150 patients newly diagnosed with OAB syndrome, divided into three groups of 50 each (antimuscarinic alone, antimuscarinic + HA-CS, and antimuscarinic drop-out patients).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:46.761407+00:00"}
{"study_id": 7198, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the antiviral efficacy of fucosylated chondroitin sulfates (FCS) against Enterovirus 71 (EV71) and analyze how structural variations influence its activity.", "results_summary": "The study demonstrated potent antiviral effects of FCS against EV71, with molecular weight, sulfated fucose branches, and sulfation pattern being key factors. Molecular weight was identified as the most significant determinant of antiviral potency.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:48.869656+00:00"}
{"study_id": 7199, "supplement_id": 1021, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of condoliase chemonucleolysis (CC) in treating lumbar disc herniation (LDH) and explore the potential of chondroitin sulfate ABC endolyase as an alternative.", "results_summary": "Condoliase provided effective and prompt relief of leg pain, with significant reductions observed within a day of treatment, though concerns about long-term safety, including disc height reduction, persist. Chondroitin sulfate ABC endolyase shows potential as a safer and more effective alternative but requires further research.", "population_specificity": "Patients with lumbar disc herniation (LDH).", "effective_dosage": "Up to 1.25 U of condoliase.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:49.963934+00:00"}
{"study_id": 7200, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether oxidized chondroitin sulfate-natamycin (ON) eye drops could effectively treat fungal keratitis by inhibiting fungal growth, promoting corneal repair, enhancing drug bioavailability, and controlling inflammation.", "results_summary": "ON eye drops inhibited fungal growth, disrupted mycelium structure, promoted corneal epithelial cell proliferation, extended drug residence time in tears, reduced clinical scores and fungal load, restored corneal stroma, and decreased inflammatory markers (TLR-4, LOX-1, IL-1\u03b2, TNF-\u03b1).", "population_specificity": "Murine (mouse) models with fungal keratitis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:52.025799+00:00"}
{"study_id": 7204, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify and characterize antibody fragments targeting oncofetal chondroitin sulfate (ofCS) for potential therapeutic and diagnostic applications in cancer.", "results_summary": "The study found that anti-ofCS antibody fragments exhibited high binding affinity to ofCS across various solid tumor types with minimal binding to normal or benign tissues, and demonstrated efficacy in disrupting tumor progression in animal models.", "population_specificity": "Animal models of human and murine cancers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:52.816038+00:00"}
{"study_id": 7202, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of chondroitin sulfate C (CSC) delivered via dissolving microneedles (cMN) combined with human adipose stem cell-derived extracellular vesicles (hASC-EV) for treating rheumatoid arthritis (RA) in a non-invasive manner.", "results_summary": "The study found that EV@cMN significantly suppressed activated fibroblast-like synoviocytes and M1 macrophages, downregulated pro-inflammatory cytokines, and facilitated chondrogenic differentiation, showing outstanding therapeutic effects comparable to wild-type mice without significant adverse effects.", "population_specificity": "Mice with collagen-induced arthritis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:53.294852+00:00"}
{"study_id": 7201, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the therapeutic potential of the semi-synthesized chondroitin sulfate analog CS-semi5 in treating osteoarthritis by assessing its cartilage-protecting, anti-inflammatory, and analgesic properties.", "results_summary": "CS-semi5 alleviated inflammation, provided analgesic effects, and protected cartilage in OA rat models. It reduced cartilage degeneration and maintained matrix homeostasis by inhibiting matrix breakdown through the miR-122-5p/p38/MMP13 axis.", "population_specificity": "OA rat models (modified Hulth and papain-induced) and samples from OA patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:53.865640+00:00"}
{"study_id": 7205, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether maternal Chondroitin sulfate (CS) supplementation could protect offspring from hypertension induced by an adenine diet in rats.", "results_summary": "Maternal CS supplementation effectively prevented hypertension in offspring, linked to improved H2S production and beneficial gut microbiota changes, including increased abundance of Roseburia hominis and Ruminococcus gauvreauii.", "population_specificity": "Pregnant rats and their offspring (animal study).", "effective_dosage": "3% CS in diet.", "study_duration": "Throughout gestation and lactation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:55.081944+00:00"}
{"study_id": 7203, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to characterize the enzymatic extraction efficiency and structural properties of chondroitin sulfate (CS) and collagen from chicken sternal cartilage for potential industrial applications.", "results_summary": "The study found that CS extraction was most efficient after 6 hours of enzymatic treatment, yielding an average molecular weight of 80.27 kDa, with chondroitin-4-sulfate being the predominant type. The CS maintained a clustered structure, suggesting suitability for food and pharmaceutical uses.", "population_specificity": "Chicken sternal cartilage (in vitro study, no human or animal subjects).", "effective_dosage": "Not specified.", "study_duration": "Enzymatic hydrolysis treatment times varied (6 hours for CS, 24 hours for collagen).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:56.212900+00:00"}
{"study_id": 7206, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop an injectable drug delivery system (DDS) using chondroitin sulfate (CS) or its modified form (CSOX) to deliver minocycline for Multiple Sclerosis therapy, focusing on controlled release and biological activity.", "results_summary": "The study found that the DDS with CSOX reduced burst release by 88% and achieved 50% release over 127 hours, with maintained biological activity (reduced IL-6 secretion). The system exhibited precise control over minocycline release kinetics and integration into an implanted device.", "population_specificity": "Not specified (in vitro or preclinical study implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:58.994892+00:00"}
{"study_id": 7207, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the utility of chondroitin sulfate C (CSC) modified for controlled nitric oxide (NO) delivery (CSC-HEDA/NO) in promoting wound healing through in vitro and in vivo models.", "results_summary": "The study found that CSC-HEDA/NO demonstrated potential in promoting wound healing by enhancing cell proliferation and migration in vitro and showing efficacy in an in vivo wound model. The combination of NO and GAG biopolymers was highlighted as a promising therapeutic approach due to their immunomodulatory and antibacterial properties.", "population_specificity": "Not specified (in vitro and in vivo models used).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:00.634489+00:00"}
{"study_id": 7209, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether modifying exosomes with chondroitin sulfate (CS) enhances targeted drug delivery and cytotoxicity in pancreatic cancer cells.", "results_summary": "Chondroitin sulfate-modified exosomes showed improved targeting of CD44-positive pancreatic cancer cells, enhanced curcumin delivery, and increased cytotoxicity and apoptosis compared to unmodified exosomes.", "population_specificity": "Pancreatic cancer cells (AsPC-1) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:01.146364+00:00"}
{"study_id": 7210, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to study the electrostatic complexation of beta-lactoglobulin with chondroitin sulfate to form stable nanoparticles for potential drug delivery applications.", "results_summary": "The study found that chondroitin sulfate formed well-defined nanoparticles at pH 4, which exhibited stability after thermal treatment and in high salinity solutions. The addition of Tween 80 enhanced hydrophobicity and colloidal stability without affecting \u03b6-potential.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "1 month (colloidal stability assessment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:01.574824+00:00"}
{"study_id": 7211, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not address Chondroitin; it focuses on evaluating a combination therapy of Hirudoid and fractional CO2 laser for burn scar treatment.", "results_summary": "The study does not report any findings related to Chondroitin.", "population_specificity": "Patients who have undergone burn repair surgery.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:01.716382+00:00"}
{"study_id": 7208, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate whether chondroitin and glucosamine sulphates (CGS) could delay collagen degeneration and reduce TNF-\u03b1 levels in rabbits with chemically induced osteoarthritis of the temporomandibular joint (TMJ).", "results_summary": "The treatment group showed increased collagen area in the articular disc and significantly lower TNF-\u03b1 levels compared to the osteoarthritis group, suggesting CGS delayed collagen degeneration and reduced inflammation. However, the collagen concentration increase was not statistically significant between groups.", "population_specificity": "36 male rabbits with chemically induced osteoarthritis in the TMJ.", "effective_dosage": "7.5 mg/kg of chondroitin sulphates and glucosamine administered subcutaneously.", "study_duration": "Treatment began 10 days post-induction, with euthanasia at 40 and 100 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:03.526523+00:00"}
{"study_id": 7212, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether chondroitin sulfate (CS) could effectively target tumors via CD44 receptors and enhance calcium overload-induced pyroptosis in colorectal cancer (CRC) cells when combined with kaempferol (KAE) in nanoparticle form.", "results_summary": "The study found that CS-HAP@KAE NPs successfully bound to tumor cells, released calcium in the acidic tumor microenvironment, and induced pyroptosis, transforming the tumor microenvironment from \"cold\" to \"hot.\" This was associated with endoplasmic reticulum stress and activation of the interferon regulatory pathway.", "population_specificity": "Colorectal cancer (CRC) cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:04.918880+00:00"}
{"study_id": 7213, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of methacrylated chondroitin sulfate (MCS) in polyHIPE scaffolds for enhancing osteogenesis and chondrogenesis in vitro.", "results_summary": "The study found that HEMA-MCS scaffolds significantly increased alkaline phosphatase (ALP), calcium content, glycosaminoglycan (GAG), and hydroxyproline production compared to other scaffold groups, indicating enhanced osteogenic and chondrogenic activity. The results suggest that incorporating MCS into polyHIPE scaffolds improves cell adherence, proliferation, differentiation, and extracellular matrix formation.", "population_specificity": "Mouse preosteoblast MC3T3-E1 cells and primary rat chondrocytes (harvested from male Wistar rats).", "effective_dosage": "Not specified", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:05.851833+00:00"}
{"study_id": 7214, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether chondroitin sulfate (CS) functionalized microspheres could effectively deliver IL-1ra to mitigate inflammation and promote extracellular matrix (ECM) synthesis in intervertebral disc degeneration (IVDD).", "results_summary": "The study found that CS-functionalized microspheres (GelMA-CS) effectively delivered IL-1ra, reducing inflammation, maintaining intervertebral disc height and water content, and promoting ECM synthesis in both in vitro and in vivo experiments. The microspheres demonstrated good biocompatibility, tissue retention, and sustained release properties.", "population_specificity": "The study focused on intervertebral disc degeneration (IVDD) models, both in vitro (NP cells) and in vivo (animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:09.382712+00:00"}
{"study_id": 7216, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the potential of a hydrogel system containing chondroitin sulfate for bone tissue regeneration, focusing on its bioactivity, biocompatibility, and antibacterial properties.", "results_summary": "The study found that the hydrogel system with chondroitin sulfate exhibited bioactivity, biocompatibility, and antibacterial activity, and supported prolonged drug release (up to 22 days) while promoting bone remodeling in vitro.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:09.884673+00:00"}
{"study_id": 7215, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether a polyethyleneimine-modified chondroitin sulfate derivative (PEI-CS) could effectively deliver ODN YW002 to RAW 264.7 cells and regulate inflammation in vitro and in a mouse periodontitis model.", "results_summary": "PEI-CS formed stable nanocomplexes with YW002, delivered it effectively into cells, and significantly reduced inflammatory markers (IL-1\u03b2, IL-6, TNF-\u03b1). It also inhibited periodontitis and alveolar bone resorption in mice.", "population_specificity": "RAW 264.7 cells and a mouse periodontitis model.", "effective_dosage": "PEI-CS/YW002 nanocomplexes at a mass ratio of 4:1.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:10.722752+00:00"}
{"study_id": 7217, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the anti-cervical cancer activity of chondroitin sulfate-functionalized selenium nanoparticles (SeCS) and elucidate their mechanism of action.", "results_summary": "SeCS inhibited HeLa cell proliferation in a dose- and time-dependent manner, inducing S-phase arrest and apoptosis via modulation of cyclin A, CDK2, p21, Bax, Bcl-2, and caspase activation, with elevated ROS levels playing a role. SeCS showed potential as a therapeutic agent or adjuvant for cancer.", "population_specificity": "HeLa cells (human cervical cancer cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:10.945811+00:00"}
{"study_id": 7218, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cognitive intervention effects of low-molecular-weight chondroitin sulfates (LMWCSs) in mice with LPS-induced inflammation and assess their antioxidant, anti-inflammatory, and gut microbiota-modulating properties.", "results_summary": "The study found that LMWCSs (CS-1 and CS-2) reduced serum inflammatory factors (TNF-\u03b1 and IL-1\u03b2), increased brain GSH levels, and decreased lipid peroxidation (MDA), mitigating LPS-induced cognitive impairment. Additionally, LMWCSs altered gut microbiota composition, increasing beneficial bacteria and reducing harmful ones.", "population_specificity": "Mice with LPS-induced inflammation.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:11.268499+00:00"}
{"study_id": 7219, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to characterize chondroitin sulfate (CS) extracted from corb heads and evaluate its potential as an anticoagulant agent.", "results_summary": "The study identified CS with high sulfate content and specific structural properties, demonstrating concentration-dependent anticoagulant effects by prolonging aPTT and TT without affecting platelet function. The findings suggest CS from corb heads may be promising for anticoagulant therapy, though clinical validation is needed.", "population_specificity": "Not specified (in vitro or animal study implied).", "effective_dosage": "200 \u03bcg/mL (concentration tested).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:12.529320+00:00"}
{"study_id": 7221, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the role of CHPF in colorectal cancer (CRC) progression and its potential as a therapeutic target.", "results_summary": "The study found that CHPF was significantly upregulated in CRC tumor tissues, promoting cell proliferation, migration, and tumor progression, while its inhibition suppressed these effects. Mechanistically, CHPF enhanced VEGFB expression via E2F1-mediated transcription, and suppressing VEGFB mitigated CHPF's oncogenic effects.", "population_specificity": "Colorectal cancer cell lines and xenograft mouse models.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:14.689492+00:00"}
{"study_id": 7220, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of Artneo (AN) with a combination of glucosamine hydrochloride and chondroitin sulfate (GC) in treating knee osteoarthritis (OA).", "results_summary": "The study found that both AN and GC improved WOMAC scores and reduced pain, with AN showing greater reductions in stiffness and synovitis area. AN also improved quality of life (SF-36 physical component) more than GC after 3 months.", "population_specificity": "70 patients with stages I-III primary knee osteoarthritis.", "effective_dosage": "GC was administered according to the standard regimen (specific dosage not detailed in the abstract).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:14.722874+00:00"}
{"study_id": 7222, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of a chondroitin sulfate-based nanocarrier (PCCE) for combined chemotherapy and anti-angiogenic therapy in treating malignant tumors.", "results_summary": "The PCCE system demonstrated enhanced antitumor properties, effectively inhibiting tumor cell proliferation, migration, and invasion while promoting apoptosis and anti-angiogenic effects. In vivo studies showed potent antitumor efficacy with no toxic side effects in B16F10 xenograft mouse models.", "population_specificity": "B16F10 xenograft mouse models (malignant tumors).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:17.954463+00:00"}
{"study_id": 7223, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of chondroitin sulfate (CS) chains and CHPF in breast cancer progression and assess the potential of a CS-binding peptide (C6S-p) to inhibit tumor growth.", "results_summary": "High expression of CHPF and SDC1 in breast cancer tissue worsened patient prognosis, and CHPF supported CS-SDC1 stabilization, modulating macropinocytosis. C6S-p bound CS-SDC1, suppressed macropinocytosis, and inhibited tumor growth in vivo.", "population_specificity": "Primary breast cancer tissue and breast cancer cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:19.513814+00:00"}
{"study_id": 7224, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of chondroitin sulfate-modified nanocapsules (CS-Cur-TGNCs) loaded with curcumin for targeting inflamed joints and treating rheumatoid arthritis (RA) and gouty arthritis (GA).", "results_summary": "CS-Cur-TGNCs demonstrated MMP-2-responsive drug release, significantly reduced oxidative stress, promoted macrophage polarization, decreased inflammatory factors (TNF-\u03b1, IL-1\u03b2, IL-6), and alleviated joint swelling in RA and GA.", "population_specificity": "Study focused on in vitro and likely animal models (not explicitly stated for human trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:19.983487+00:00"}
{"study_id": 7227, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the therapeutic potential of targeting chondroitin sulfate proteoglycan 4 (CSPG4) in cancer immunotherapy, focusing on its role in tumor progression and metastasis.", "results_summary": "The study found that CSPG4 is a promising target for cancer therapy due to its involvement in tumor proliferation, migration, and neoangiogenesis. Various strategies, including CAR T-cell therapy and monoclonal antibodies, showed potential in targeting CSPG4, with overexpression linked to adverse prognostic outcomes.", "population_specificity": "Diverse tumors (not specified further)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:20.498654+00:00"}
{"study_id": 7226, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify cell-specific DNA methylation changes associated with chondroitin sulphate response in Kashin-Beck disease (KBD) patients.", "results_summary": "The study revealed significant differential DNA methylation patterns (hypermethylated and hypomethylated regions) linked to chondroitin sulphate response, with specific genes like CHL1, RIC8A, and SOX12 showing altered methylation and expression levels. Cell-specific methylation changes were observed in granulocytes, monocytes, and B cells.", "population_specificity": "Kashin-Beck disease (KBD) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:20.632750+00:00"}
{"study_id": 7228, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether an oral preparation containing chondroitin sulfate, combined with other compounds, could improve sexual and urinary symptoms in reproductive-age participants with recurrent urinary tract infections (rUTIs).", "results_summary": "The study found that the intervention group showed significant early improvements in sexual (FSFI) and urinary (IPSS) symptoms compared to the control group, with effects persisting after crossover. However, long-term follow-up results were comparable between groups.", "population_specificity": "Reproductive-age participants with recurrent urinary tract infections (rUTIs).", "effective_dosage": "Once daily for 3 months (exact dosage not specified).", "study_duration": "3 months per treatment phase, with a crossover at 3 months for an additional 3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:22.376129+00:00"}
{"study_id": 7230, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether acrylated chondroitin sodium sulfate (CSA) combined with other compounds could simultaneously remove LDL and exhibit anti-inflammatory effects to stabilize atherosclerotic plaques.", "results_summary": "The study found that AA-CSA-CD-R microspheres effectively adsorbed LDL (614.73 mg/g static capacity, 150.97 mg/g dynamic capacity) and demonstrated significant anti-inflammatory effects by reducing iNOS, TNF-\u03b1, and IL-6 levels in macrophages.", "population_specificity": "Mouse macrophages (in vitro) and simulated perfusion experiments (no human or animal in vivo data mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:23.769877+00:00"}
{"study_id": 7229, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to optimize the enzymatic synthesis of chondroitin sulfate A (CSA) by enhancing the expression of chondroitin 4-O-sulfotransferase (C4ST) and developing a one-pot enzymatic system for large-scale CSA production.", "results_summary": "The study achieved a 43.7-fold increase in active C4ST expression (2713.1 U/L) and constructed a one-pot enzymatic system for CSA biosynthesis, achieving a sulfonation degree of up to 97.0%. These improvements promise scalable CSA production with customizable sulfonation degrees.", "population_specificity": "Not applicable (in vitro study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:24.284323+00:00"}
{"study_id": 7231, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate changes in chondroitin sulfate proteoglycan (CSPG) expression following traumatic brain injury (TBI) and assess whether targeting CSPG side chains with chondroitinase ABC (ChABC) could influence synaptic reorganization and neurogenesis.", "results_summary": "The study found that CSPG moieties change after injury, potentially enabling synaptic reorganization, and that ChABC treatment targeting CSPG side chains reduced GABA receptor mRNA and aromatase expression, suggesting a role in modulating neuroplasticity.", "population_specificity": "Adult male and female zebra finches with induced bilateral penetrating brain injury.", "effective_dosage": "Not specified", "study_duration": "1- or 7-days post-injury", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:27.522273+00:00"}
{"study_id": 7232, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the characteristics, properties, uses, sources, and extraction methods of chondroitin sulphates (CSs), emphasizing the need for environmentally friendly extraction and purification processes.", "results_summary": "The study highlights the diverse applications of CSs, including osteoarthritis treatment and tissue engineering, while noting that production methods impact bio-functional properties. It calls for greener extraction technologies to ensure quality and bioactivity.", "population_specificity": "Not specified (broad review of CSs across organisms and applications)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:28.542057+00:00"}
{"study_id": 7234, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy and safety of Chondroitin Sulfate (CS) and its combination with Glucosamine Sulfate (GS) in managing knee osteoarthritis (KOA).", "results_summary": "Chondroitin Sulfate showed significant reduction in pain intensity and improved physical function compared to placebo, with a good safety profile. The combination of CS and GS did not significantly improve symptoms or modify the disease.", "population_specificity": "Patients with knee osteoarthritis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:28.718866+00:00"}
{"study_id": 7233, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of chondroitin sulphate-modified MoS2 nanoenzyme (CS@MoS2) for anti-Alzheimer's disease intervention by assessing its effects on A\u03b2 aggregation, oxidative stress, and neuroinflammation.", "results_summary": "CS@MoS2 significantly inhibited A\u03b21-40 aggregation, protected SH-SY5Y cells from oxidative stress and toxic injury, modulated intracellular Ca2+ imbalance, downregulated Tau hyperphosphorylation, and improved spatial learning and memory in AD mice.", "population_specificity": "D-gal/AlCl3-induced AD mice and SH-SY5Y cells (a human neuroblastoma cell line).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:29.361805+00:00"}
{"study_id": 7235, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a hydrogel dressing containing chondroitin sulfate (CS) could enhance infected wound healing by promoting antibacterial activity and angiogenesis.", "results_summary": "The GSC hydrogel demonstrated excellent antibacterial performance and promoted type H vessel differentiation in endothelial cells, accelerating the regeneration of infected skin defects in vivo.", "population_specificity": "In vitro and in vivo models (not specified if human or animal, but likely animal given the context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:30.116626+00:00"}
{"study_id": 7236, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how chondroitin sulfate isomers on versican (VCAN) influence T-cell trafficking in the tumor microenvironment and their role in immunotherapy response.", "results_summary": "The study found that chondroitin sulfate isomers on VCAN have opposing roles\u2014either supporting or inhibiting T-cell trafficking\u2014and that removing glycosaminoglycans (GAGs) mitigates these effects. VCAN and its chondroitin sulfate modifications were identified as key components of the ECM immunologic barrier affecting T-cell invasion.", "population_specificity": "Primary triple-negative breast cancer tissues.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:31.497197+00:00"}
{"study_id": 7237, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop chondroitin sulfate-based nanoparticles for targeted drug delivery of Chlorambucil and Doxorubicin to cancer cells.", "results_summary": "The study demonstrated that chondroitin sulfate nanoparticles effectively released drugs selectively in cancer cells (41% Chl and 60% DOX release) compared to healthy cells, enhancing cytotoxic activity against cancer cells.", "population_specificity": "MDA-MB-231 cancer cells and healthy cells in vitro.", "effective_dosage": "Not specified.", "study_duration": "2 hours for Chl release, 96 hours for DOX release.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:32.630238+00:00"}
{"study_id": 7238, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of chondroitin sulfate A (CSA)-based nanoparticles for targeted delivery of chlorin e6 (Ce6) and doxorubicin (DOX) in combined chemo-photodynamic therapy against triple-negative breast cancer.", "results_summary": "The study found that CSA-based nanoparticles (CSSC-D) demonstrated reduction-sensitive drug release, enhanced reactive oxygen species (ROS) generation under NIR irradiation, and potent tumor growth inhibition in triple-negative breast cancer models. The nanoparticles showed improved cytotoxic effects against 4T1 and MDA-MB-231 cells and significant tumor growth inhibition in mice.", "population_specificity": "Triple-negative breast cancer cells (4T1 and MDA-MB-231) and 4T1-bearing Balb/c mice.", "effective_dosage": "Chemically attached Ce6 (1.53%) and physically encapsulated DOX (8.11%) in nanoparticles.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:36.049669+00:00"}
{"study_id": 7240, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to characterize how Chondroitin sulfate (CS) is degraded by the human gut microbiota and identify the microbial species responsible for this process.", "results_summary": "The study found that human gut microbiota uniquely degrades CS into unsaturated CS oligosaccharides (CSOSs) and short-chain fatty acids, with Bacteroides salyersiae being the most effective degrader. The produced CSOSs also supported the growth of secondary degraders like Bacteroides stercoris.", "population_specificity": "Human gut microbiota from 23 fecal samples.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:37.001057+00:00"}
{"study_id": 7241, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether functionalizing collagen surface films with chondroitin sulfate could improve cell adhesion, proliferation, and morphological organization in U87 glioblastoma cells.", "results_summary": "The study found that oxygen nonthermal plasma treatment and glyco-conjugation with chondroitin sulfate enhanced surface properties, leading to improved adhesion, proliferation, and morphological organization of U87 glioblastoma cells. These results suggest potential applications for collagen-based biomaterials in advanced in vitro models.", "population_specificity": "U87 glioblastoma cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:37.449591+00:00"}
{"study_id": 7239, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the stability, cellular uptake mechanism, apoptosis induction, antitumor activity, and safety of chondroitin sulfate-modified antiangiogenic peptide CS-EA.", "results_summary": "CS-EA demonstrated superior stability, effective cellular uptake via clathrin-mediated endocytosis, and induced apoptosis in endothelial cells by modulating Bcl-2, mitochondrial membrane potential, cytochrome c, Caspase 3, and reactive oxygen species. It showed significantly higher antitumor activity in a B16 xenografted tumor model without harmful effects on vital organs.", "population_specificity": "Mice with B16 xenografted tumors and EAhy926 endothelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:37.823626+00:00"}
{"study_id": 7243, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of chondroitin sulfate proteoglycan 4 (CSPG4) in epithelial ovarian cancer (EOC), focusing on its impact on cell-cell interactions, spheroid formation, and peritoneal metastasis.", "results_summary": "CSPG4 was associated with aggressive EOC features and poor prognosis. Knockdown of CSPG4 significantly reduced cell proliferation, migration, invasion, spheroid formation, and peritoneal metastasis in vivo.", "population_specificity": "Patients with advanced epithelial ovarian cancer and EOC cell lines (e.g., ES2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:39.069505+00:00"}
{"study_id": 7244, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether chondroitin sulfate-derived micelles, combined with celastrol and phenformin, could effectively target adipose tissues to reduce inflammation and improve metabolic outcomes in obesity.", "results_summary": "The study found that chondroitin sulfate-derived micelles effectively targeted adipose tissues via CD44-mediated pathways, significantly reducing inflammation, lipid accumulation, and improving glucose homeostasis in high-fat diet-fed mice.", "population_specificity": "High-fat diet-fed mice (animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:39.891049+00:00"}
{"study_id": 7242, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of a single intraarticular injection of hybrid cooperative complexes (HA-SC) containing chondroitin for symptomatic knee osteoarthritis.", "results_summary": "The study found that a single HA-SC injection was safe and well-tolerated, with significant reductions in pain, stiffness, and physical function limitations. Only 18.1% of patients required a second injection, and no serious adverse events were reported.", "population_specificity": "Patients with symptomatic knee osteoarthritis (Kellgren-Lawrence Grade 2-3) and a VAS pain score \u22654.", "effective_dosage": "1.6% sodium chondroitin in combination with 2.4% sodium hyaluronate, administered as a single intraarticular injection (with a second injection at day 30 if needed).", "study_duration": "Follow-up visits occurred over an unspecified period, with a second injection option at day 30.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:40.425870+00:00"}
{"study_id": 7245, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the principal mode of action (MoA) of Ialuril\u00ae Prefill (containing chondroitin sulfate) in reducing urinary tract infections by assessing its film-forming properties and ability to counteract bacterial adhesion on human bladder epithelium.", "results_summary": "The study found that HA+CS+CaCl2 significantly reduced caffeine permeation (51.7% at 1h, 38.1% at 2h), indicating strong adherence to the bladder epithelium, and counteracted E. coli biofilm formation without inhibiting bacterial growth. SEM images confirmed homogeneous product distribution and adherence to the bladder surface.", "population_specificity": "3D reconstructed human bladder epithelium (HBE)", "effective_dosage": "Sodium chondroitin sulfate 2% w/v (combined with sodium hyaluronate 1.6% and calcium chloride 0.87%)", "study_duration": "15 min exposure for film-forming evaluation; 4h and 24h for bacterial growth assessment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:44.196733+00:00"}
{"study_id": 52256, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of Syndecan-1 (SDC-1), which includes chondroitin sulfate glycosaminoglycan side chains, in health and disease, focusing on its mechanisms and therapeutic potential.", "results_summary": "The abstract highlights SDC-1's involvement in various diseases but does not specifically report on chondroitin's effects or outcomes.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:45.115414+00:00"}
{"study_id": 7246, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of chondroitin sulfate (CS) and CSPG4 in the maintenance and differentiation of glioma-initiating cells (GICs) and their potential as therapeutic targets for malignant glioma.", "results_summary": "The study found that CS-CSPG4 is critical for GIC maintenance, with CS degradation inducing differentiation and CSPG4 knockdown suppressing GIC growth. CS-CSPG4 regulates integrin signaling, suggesting it as a potential target for glioma therapy.", "population_specificity": "Glioma stem cell/glioma-initiating cell (GIC) clones derived from patient tumors with glioblastoma potential.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:45.609215+00:00"}
{"study_id": 52257, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the diagnostic accuracy of chondroitin sulfate (CS) as a biomarker for early cancer detection, particularly in ovarian and renal cancers.", "results_summary": "Chondroitin sulfate disaccharides showed promise as diagnostic markers in ovarian cancer and potential in renal cancer, but no significant differences were found in urinary CS levels between prostate cancer patients and controls.", "population_specificity": "Patients with various cancers, including renal cell carcinoma, ovarian cancer, and prostate cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:46.117934+00:00"}
{"study_id": 7247, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate in nanocarriers for colon-targeted drug delivery, particularly for colon cancer therapy.", "results_summary": "The abstract highlights chondroitin sulfate's therapeutic functions (anti-inflammatory, anti-osteoarthritis, etc.) and its potential as a matrix material, coat, or targeting ligand in nanocarriers for colon cancer therapy. It also discusses future applications of CS in drug delivery.", "population_specificity": "Not specified (focused on drug delivery mechanisms rather than human trials).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:47.223169+00:00"}
{"study_id": 52260, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate as a functionalizing biomolecule for albumin nanoparticles to enhance tumor-targeted drug delivery.", "results_summary": "The abstract mentions that chondroitin sulfate, among other biomolecules, enables specific recognition and binding to cancer cells, improving tumor-specific drug delivery and reducing off-target effects. However, no specific results for chondroitin alone are detailed.", "population_specificity": "Not specified (general discussion of albumin nanoparticles for anticancer drug delivery).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:48.204089+00:00"}
{"study_id": 52259, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop a high-throughput method for quantifying glycosaminoglycans (GAGs), including chondroitin sulfate, in biofluids using UHPLC-MS/MS.", "results_summary": "The study successfully developed a scalable, precise, and reproducible UHPLC-MS/MS method for analyzing 17 disaccharides from chondroitin sulfate, heparan sulfate, and hyaluronic acid, suitable for clinical biomarker applications. The protocol allows processing up to 82 samples per 96-well plate with a total analysis time of ~1.5 days plus 15 minutes per sample.", "population_specificity": "Not specified (methodological study)", "effective_dosage": "Not available", "study_duration": "Not applicable (methodological study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:48.582359+00:00"}
{"study_id": 52262, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically review the properties, applications, and outcomes of CAQK (a peptide binding to chondroitin sulfate proteoglycans) as a therapeutic agent or homing molecule in CNS disorders.", "results_summary": "The review found that CAQK conjugation facilitated targeted delivery of therapeutic agents to CNS tissues, with most studies showing benefits in brain and spinal cord injury models. However, no studies directly evaluated CAQK alone, and methodological heterogeneity limited direct comparisons.", "population_specificity": "Predominantly mice and rats, with no human studies mentioned.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:49.059598+00:00"}
{"study_id": 52263, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of chondroitin-sulfate as a mucosal protectant in the treatment of GERD, alongside other pharmacological options.", "results_summary": "The abstract mentions chondroitin-sulfate as a mucosal protectant for GERD but does not provide specific efficacy data; it highlights the need for careful assessment of therapeutic options based on patient characteristics.", "population_specificity": "Patients with GERD, including those with mucosal damage or normal esophageal mucosa.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:52.569240+00:00"}
{"study_id": 52265, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers examined how carbohydrate polymers, including chondroitin sulfate, can enhance drug delivery systems for colon cancer treatment.", "results_summary": "The abstract highlights that modifying carbohydrate polymers like chondroitin sulfate improves drug loading, stability, and release patterns, enhancing the therapeutic index of chemotherapeutic drugs. Combining these polymers with advanced technologies enables precise, stimuli-responsive drug delivery.", "population_specificity": "Not specified (general focus on drug delivery systems for colon cancer treatment).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:52.941245+00:00"}
{"study_id": 52267, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the latest developments in polysaccharide-based crosslinking agents, including chondroitin sulfate, for biomedical scaffolds.", "results_summary": "The abstract highlights that polysaccharides, including chondroitin sulfate, enhance scaffold mechanical strength and biocompatibility while providing bioactivity such as immune regulation and anti-inflammation. No specific results on chondroitin sulfate alone are detailed.", "population_specificity": "Not specified (review article, not a clinical study).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:54.611802+00:00"}
{"study_id": 52266, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate (CS) in cellular mechanosensing pathways and its potential as a therapeutic target for mechano-driven pathologies like cancer and inflammation.", "results_summary": "The study highlights that chondroitin sulfate, as part of glycosaminoglycans (GAGs) and proteoglycans (PGs), modulates cellular responses to mechanical stimuli and is implicated in maintaining tissue homeostasis. Dysregulation of these pathways is linked to diseases such as cancer and inflammation, suggesting therapeutic potential.", "population_specificity": "Not specified (general focus on cellular and tissue-level mechanisms)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:55.140020+00:00"}
{"study_id": 52270, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the use of polysaccharide-based hydrogels, including chondroitin sulfate, in biomedical applications and discuss their reinforcement with nanomaterials.", "results_summary": "The abstract highlights that polysaccharide-based hydrogels, including chondroitin sulfate, are biocompatible but require reinforcement to improve their physicochemical and mechanical properties for specific applications.", "population_specificity": "Not specified (general biomedical applications)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:56.878437+00:00"}
{"study_id": 52271, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the use of biodegradable polymers, including chondroitin sulfate, in developing tissue adhesives for biomedical applications.", "results_summary": "The abstract highlights chondroitin sulfate as one of several natural biodegradable polymers used in tissue adhesives, but it does not provide specific findings on its effects. The review focuses on the degradability and applications of these adhesives.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:57.249509+00:00"}
{"study_id": 52269, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to provide an overview of glycosaminoglycans (GAGs), including chondroitin sulfate, focusing on their synthesis, degradation, biological roles, and measurement methods, as well as their association with metabolic disorders like mucopolysaccharidoses (MPS).", "results_summary": "The abstract discusses the role of GAGs, including chondroitin sulfate, in metabolic disorders and their accumulation due to lysosomal enzyme deficiencies, but does not provide specific findings on chondroitin's effects.", "population_specificity": "Not specified (general discussion of GAGs in metabolic disorders and other conditions).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:57.523361+00:00"}
{"study_id": 52273, "supplement_id": 1021, "safety_score": "26", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to assess the effectiveness and safety of Chondroitin sulfate in treating hand osteoarthritis compared to other drug interventions.", "results_summary": "Chondroitin sulfate showed the highest incidence of adverse events among the studied agents, with no substantial improvement in functional index scores for hand osteoarthritis compared to placebo.", "population_specificity": "Patients with hand osteoarthritis (total of 3965 patients across 21 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:00.615133+00:00"}
{"study_id": 52268, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether plasma levels of oncofetal chondroitin sulfate (ofCS)-modified CD44 could predict survival outcomes in patients with lung cancer.", "results_summary": "High expression of ofCS-modified CD44 was associated with significantly worse overall survival (OS) and progression-free survival (PFS) in lung cancer patients. The prognostic nomogram based on ofCS-modified CD44 levels showed good predictive accuracy for OS.", "population_specificity": "274 newly diagnosed lung cancer patients at Sun Yat-sen University Cancer Center (2013-2015).", "effective_dosage": "Not specified", "study_duration": "Not specified (observational cohort study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:01.063424+00:00"}
{"study_id": 52278, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Chondroitin, among other TCM active ingredients, to enhance osteoporotic defect healing by regulating bone homeostasis.", "results_summary": "The study suggests Chondroitin, as part of TCM active ingredients, may regulate bone homeostasis by stimulating bone formation and inhibiting bone resorption, potentially improving osteoporotic defect healing when used in bone repair scaffolds.", "population_specificity": "Osteoporotic defect healing (no specific demographic details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:03.155459+00:00"}
{"study_id": 52279, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize key biological findings related to glycosaminoglycans (GAGs), including chondroitin sulfate, and identify major processes needing further study to understand their biological functions.", "results_summary": "The abstract does not provide specific results on chondroitin's effects but highlights areas for future research, such as biosynthesis regulation, functional characterization, and potential therapeutic applications.", "population_specificity": "Not specified (general discussion of GAGs in health and disease).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:03.559733+00:00"}
{"study_id": 52275, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 76, "quality_score": 82, "study_goal": "The researchers aimed to evaluate the safety and efficacy of vestronidase alfa (recombinant human GUS) in reducing urinary glycosaminoglycans (uGAGs), including chondroitin sulfate (CS), in patients with MPS VII.", "results_summary": "The study observed a mean reduction in CS uGAG levels by 55% from initial baseline to DMP enrollment, with further reductions maintained at months 6, 12, and 24 (-70%, -71%, -76%, respectively). The treatment demonstrated consistent efficacy in reducing CS levels over time.", "population_specificity": "Patients with Mucopolysaccharidosis VII (MPS VII), including pediatric and adult participants (mean age at enrollment: 13.9 years).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Up to 24 months of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:03.849796+00:00"}
{"study_id": 52283, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of chondroitin, among other phytochemicals, for improving cartilage structure and elasticity in osteoarthritis treatment.", "results_summary": "The abstract suggests chondroitin may improve cartilage structure and elasticity, but clinical trials are still needed for effective use in clinical practice.", "population_specificity": "Elderly population, particularly those with osteoarthritis and obesity.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:04.737296+00:00"}
{"study_id": 52280, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to elucidate the mechanisms by which gut microbiota utilize glycosaminoglycans (GAGs), including chondroitin sulfate (CS), and their enzymatic machinery.", "results_summary": "The study highlights the role of Bacteroides and lactic acid bacteria (LAB) in degrading GAGs like CS, focusing on their polysaccharide utilization loci (PULs) and enzymatic pathways. It suggests that understanding these mechanisms could inform therapeutic strategies for human health.", "population_specificity": "Gut microbiota (Bacteroides and lactic acid bacteria)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:05.682467+00:00"}
{"study_id": 52281, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore whether intracellular chondroitin sulfate synthesis and secretion could mitigate hyperglycemia-induced pathologies in diabetes.", "results_summary": "The study proposed that chondroitin sulfate synthesis could help detoxify glucose toxicity in hyperglycemic cells, potentially reducing diabetic complications like nephropathy. No direct experimental results on chondroitin's effects were provided, only a theoretical framework.", "population_specificity": "Hyperglycemic dividing cells (in vitro or theoretical context, not specified).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:07.096691+00:00"}
{"study_id": 52285, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the therapeutic applications of chondroitinases (Chase) and address the challenges limiting their use, such as thermal instability and delivery systems.", "results_summary": "The study highlights the potential medical applications of Chase, including spinal cord injury treatment and analytical uses, but notes limitations like thermal instability and delivery challenges. Recent advancements in enzyme engineering, drug delivery, and combination therapies are summarized as potential solutions.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:09.174818+00:00"}
{"study_id": 52286, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the efficacy of fish cartilage hydrolysate (FCH) on knee pain and joint function in subjects with moderate knee discomfort, as well as its potential mechanisms of action on human chondrocytes.", "results_summary": "FCH significantly improved knee pain, function, and quality of life, as measured by KOOS, VAS, and SF-36. It also reduced catabolic and pro-inflammatory factors while preserving cartilage matrix components in human chondrocytes.", "population_specificity": "33 subjects with moderate knee joint discomfort and loss of functionality.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:10.206702+00:00"}
{"study_id": 52287, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of chondroitin as a chronic pharmacological treatment for non-surgical management of knee osteoarthritis.", "results_summary": "Chondroitin was suggested as a chronic pharmacological treatment for knee osteoarthritis, alongside glucosamine, but specific efficacy data or comparative outcomes were not detailed in the abstract.", "population_specificity": "Patients with knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:10.348958+00:00"}
{"study_id": 52289, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the potential role of chondroitin sulphate as a novel key ingredient in addressing urinary tract infections.", "results_summary": "The abstract does not provide specific findings regarding chondroitin's effects, only mentioning it as a potential novel ingredient.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided in the abstract.", "study_duration": "Not provided in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:11.732459+00:00"}
{"study_id": 52288, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers sought to define patterns of plasma EGCX degradation products, including chondroitin sulfate, in children with sepsis-associated PARDS and test their association with clinical outcomes.", "results_summary": "The study found higher plasma levels of heparan sulfate and syndecan-1 in sepsis-associated PARDS patients, but chondroitin sulfate levels were not highlighted as significantly different between groups.", "population_specificity": "Children (\u22651 month to <18 years) receiving invasive mechanical ventilation for acute respiratory failure for \u226572 hours, with and without sepsis-associated PARDS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:12.295147+00:00"}
{"study_id": 52290, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the use of chondroitin sulfate as a ligand for targeting parasite-infected erythrocytes in malaria treatment.", "results_summary": "The abstract mentions chondroitin sulfate as one of the ligands decorated onto nanocarriers for specific targeting to parasite-infected erythrocytes, but no specific results regarding its effects are provided.", "population_specificity": "Not specified (study is a review, not a clinical trial).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:12.686053+00:00"}
{"study_id": 52291, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on determining the effects of Chondroitin but rather explores the role of heparan sulfate in inflammation, tissue maintenance, and bone formation.", "results_summary": "The abstract does not report specific findings related to Chondroitin; it primarily discusses heparan sulfate's structural and functional roles in modulating inflammation and promoting tissue homeostasis.", "population_specificity": "Not specified (study focuses on heparan sulfate in periodontium and alveolar bone).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:13.969808+00:00"}
{"study_id": 52292, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to examine the relationship between knee arthroscopy (UKA) and local symptom improvement, adjusting for conservative treatments including oral chondroitin sulfate.", "results_summary": "The study found no significant difference in symptom improvement between the UKA and non-UKA groups, but UKA was associated with a higher probability of new-onset grinding/clicking and frequent knee pain/aching/stiffness. Chondroitin's specific efficacy was not isolated in the results.", "population_specificity": "163 patients from the Osteoarthritis Initiative cohort who underwent unilateral knee arthroscopy, matched to 163 non-UKA patients by sex, age, abdominal circumference, and Kellgren-Lawrence grade.", "effective_dosage": "Not specified", "study_duration": "Follow-up of at least 24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:16.702962+00:00"}
{"study_id": 52293, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate-rich proteoglycans in neural plasticity, memory, cognitive processes, and their interaction with hyaluronan in the CNS/PNS extracellular matrix.", "results_summary": "The study found that chondroitin sulfate-rich proteoglycans interact with hyaluronan to stabilize perineuronal nets, contributing to neural plasticity and cognitive functions. Hyaluronan also plays a role in myelination/re-myelination and photoreceptor viability, with fragmentation observed in conditions like multiple sclerosis and traumatic brain injury.", "population_specificity": "Not specified (focused on CNS/PNS extracellular matrix mechanisms).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:18.714314+00:00"}
{"study_id": 52294, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to explore the mechanisms by which reactive astrocytes produce chondroitin sulfate proteoglycans (CSPGs) after spinal cord injury and their roles in axon regeneration, inflammation regulation, and cell migration/differentiation.", "results_summary": "The study found that CSPGs, produced by reactive astrocytes activated via extracellular traps, inhibit axon regeneration but also play beneficial roles in regulating inflammation and cell migration/differentiation. Novel therapeutic targets were proposed to mitigate CSPGs' adverse effects.", "population_specificity": "Spinal cord injury models (not human subjects).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:18.854620+00:00"}
{"study_id": 52295, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the use of nutritional supplements, including Chondroitin, in the clinical management of tendinopathies.", "results_summary": "Chondroitin was included in a proprietary blend (TENDISULFUR) used in 3 studies, suggesting potential benefits in tendinopathy management through anti-inflammatory effects and tendon healing. However, its individual efficacy was not isolated or specifically analyzed.", "population_specificity": "Individuals with tendinopathies, including athletes and the general population.", "effective_dosage": "Not specified (part of a multi-ingredient blend).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:19.059554+00:00"}
{"study_id": 52297, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of chondroitin sulfate proteoglycans in glial scar formation after spinal cord injury and discuss therapeutic strategies to promote regeneration.", "results_summary": "The abstract describes chondroitin sulfate proteoglycans as part of the glial scar barrier, which preserves healthy tissue but inhibits regeneration. Therapeutic strategies to address scar-related negative outcomes are discussed, but no specific results on chondroitin's efficacy are provided.", "population_specificity": "The study focuses on spinal cord injury models, not a specific human population.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:20.847339+00:00"}
{"study_id": 52299, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of nonsurgical interventions, including dietary supplements like chondroitin sulfate, in managing musculoskeletal pain in active military personnel.", "results_summary": "The study found that dietary supplements, including chondroitin sulfate, showed no benefit in managing musculoskeletal pain in the studied population. The evidence was based on randomized clinical trials with high risk of bias and clinical heterogeneity.", "population_specificity": "Active serving military personnel with musculoskeletal pain conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:21.711402+00:00"}
{"study_id": 52300, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of acute exercise on glycosaminoglycan (GAG) content and gene expression in human osteoarthritic cartilage.", "results_summary": "Acute exercise had minor influence on cartilage GAG dynamics, suggesting osteoarthritic cartilage is not significantly affected by acute exercise. Regional differences indicated a potential chronic mechanical influence on cartilage.", "population_specificity": "Patients with primary knee osteoarthritis (mean age 69 \u00b1 7.5 years, 58% female, BMI 29.4 \u00b1 4.4 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "Single bout of resistance exercise (one-legged leg press) initiated 3.5 hours prior to surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:23.316655+00:00"}
{"study_id": 52296, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the efficacy of intravesical GAG therapy (including chondroitin sulfate) for patients with bladder pain syndrome/interstitial cystitis (BPS/IC) with Hunner lesions using a dual RCT and aggregated N-of-1 trial design.", "results_summary": "The study design combines an RCT and aggregated N-of-1 trial to evaluate short-term and long-term efficacy, with the primary outcome being maximum bladder pain reduction measured via a visual analogue scale. Results are pending as the study is ongoing.", "population_specificity": "Patients with symptomatic BPS/IC with Hunner lesions.", "effective_dosage": "2% chondroitin sulfate + 1.6% hyaluronic acid, administered 1x/week for 6 weeks.", "study_duration": "6 weeks (short-term), followed by an open prospective part for long-term efficacy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:23.379382+00:00"}
{"study_id": 52301, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review recent advances in understanding the role of chondroitin sulfate and its associated proteoglycans in arthritis and Duchenne muscular dystrophy (DMD), focusing on their potential as biomarkers and therapeutic targets.", "results_summary": "The abstract highlights the diverse functional regulatory properties of chondroitin sulfate and its degradation products, emphasizing their potential as biomarkers and therapeutic targets for arthritis and DMD. It does not provide specific efficacy data but suggests a promising role in these pathologies.", "population_specificity": "Patients with arthritis and Duchenne muscular dystrophy (DMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:26.686903+00:00"}
{"study_id": 52302, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 50, "study_goal": "The researchers aimed to describe the clinical features and natural history of a novel VPS33A variant in a Polish patient with mucopolysaccharidosis-plus syndrome (MPS-PS), including the presence of chondroitin sulphate in urine.", "results_summary": "The study found slight presence of chondroitin sulphate in urine glycosaminoglycan electrophoresis, along with other novel clinical features in the patient. No significant therapeutic outcomes or effects of chondroitin were reported.", "population_specificity": "A single Polish patient with a novel homozygous VPS33A variant causing MPS-PS.", "effective_dosage": "Not available", "study_duration": "Over 12 years of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:27.933686+00:00"}
{"study_id": 52305, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore pathogenic pathways in sporadic inclusion body myositis (sIBM) and identify potential therapeutic targets, including the role of chondroitin sulfate biosynthesis.", "results_summary": "The study found upregulated glycosaminoglycan biosynthesis pathways, including chondroitin sulfate deposition in sIBM muscle samples, suggesting its involvement in the disease pathophysiology. Histopathological examination supported these findings, showing chondroitin sulfate deposition alongside mast cell infiltration.", "population_specificity": "14 sIBM patients and 6 non-diseased subjects (muscle biopsy samples).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:27.953649+00:00"}
{"study_id": 52304, "supplement_id": 1021, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to classify prognostic factors for successful condoliase treatment for lumbar disc herniation (LDH) and assess its effectiveness in patients under 20 and over 70 years old.", "results_summary": "Condoliase injection was effective for LDH, with 77.5% of patients showing \u226550% improvement in leg pain VAS. However, 75% of adolescent patients experienced deterioration in Pfirrmann classification, indicating potential risks for younger patients.", "population_specificity": "137 LDH patients treated at four Japanese institutions, including adolescents (<20) and elderly (\u226570).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:27.966006+00:00"}
{"study_id": 52306, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate proteoglycans (CSPGs) in spinal cord injury (SCI) scar formation and evaluate therapeutic approaches targeting cellular and non-cellular components.", "results_summary": "The study highlights promising therapeutic results from targeting CSPGs in the extracellular matrix (ECM) of spinal cord scars, alongside advancements in understanding cellular mechanisms involved in scar formation post-SCI.", "population_specificity": "Spinal cord injury (SCI) models, focusing on cellular and non-cellular components of scar formation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:30.716821+00:00"}
{"study_id": 52307, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate proteoglycans in inhibiting axon growth and contributing to synaptic loss in areas remote to spinal cord injury.", "results_summary": "The study found that reactive astrocytes produce chondroitin sulfate proteoglycans, which inhibit axon growth and damage cells, contributing to synaptic loss and neurological deterioration in areas distant from the spinal cord injury. The interplay between chronic inflammation and neurodegeneration appears pivotal in these pathological processes.", "population_specificity": "Not specified (focus on spinal cord injury pathology)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:30.812489+00:00"}
{"study_id": 52308, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify less-established neurotoxic molecules released by reactive astrocytes, including chondroitin sulfate proteoglycans (CSPGs).", "results_summary": "The study identified CSPGs as one of 14 potentially neurotoxic molecules released by reactive astrocytes, but did not provide specific data on their effects or mechanisms.", "population_specificity": "Not specified (literature review of astrocyte behavior)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:31.003823+00:00"}
{"study_id": 52310, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the evolution, limitations, and current advancements in chondroitinase-based therapy for spinal cord injury, focusing on improving delivery methods such as gene therapy.", "results_summary": "The study found that chondroitinase effectively reduces CSPG GAG chains, aiding axon regrowth, but faces challenges like thermostability and limited activity duration. Current efforts focus on optimizing delivery through viral vectors and temporal modulation of expression.", "population_specificity": "Spinal cord injury models (not specified if human or animal).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:33.165847+00:00"}
{"study_id": 52314, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of chondroitin against placebo and active treatments (e.g., curcumin, NSAIDs) on pain and function in osteoarthritis patients.", "results_summary": "The study found no significant improvement in pain or function with chondroitin compared to active treatments, though it was not directly compared to placebo in isolation.", "population_specificity": "Patients with knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:35.471435+00:00"}
{"study_id": 52313, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of nutraceuticals, including Chondroitin, in managing osteoarthritis (OA) in canine rehabilitation patients, particularly for pain control and disease progression.", "results_summary": "The abstract does not provide specific findings on Chondroitin's effects, only mentioning it as one of several nonbotanical nutraceutical interventions considered for OA management.", "population_specificity": "Canine rehabilitation patients with osteoarthritis (OA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:36.608820+00:00"}
{"study_id": 52311, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of syndecan-1, a proteoglycan containing chondroitin sulfate, in liver pathologies, including fibrogenesis, hepatocarcinogenesis, and viral infections.", "results_summary": "The study found that syndecan-1 protects against early fibrogenesis by enhancing TGF\u03b21 and THBS1 clearance, hinders hepatocarcinogenesis by interfering with signaling pathways and cell cycle blockade, and participates in viral uptake (e.g., HCV and SARS-CoV-2). Elevated syndecan-1 levels correlate with poor prognosis in liver cirrhosis and cancer.", "population_specificity": "Liver disease models, including cirrhosis, hepatocellular carcinoma (HCC), and HCV-infected livers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:36.748176+00:00"}
{"study_id": 52315, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the expression, molecular structure, and biological roles of PTPRZ, and discuss its potential as a diagnostic marker and therapeutic target for gliomas and demyelinating diseases.", "results_summary": "The study found that PTPRZ is highly expressed in the central nervous system and may serve as a therapeutic target for gliomas. A soluble form of PTPRZ (sPTPRZ) in cerebrospinal fluid is upregulated in glioma patients, suggesting its potential as a diagnostic biomarker. Additionally, PTPRZ is involved in remyelination in multiple sclerosis, with reduced glycosylation enhancing remyelination in mouse models.", "population_specificity": "Mouse models of glioma and demyelination, and human glioma patients.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:39.028783+00:00"}
{"study_id": 52317, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the spatiotemporal diversity of glycosaminoglycans (GAGs), including Chondroitin, and their roles in human biology and disease.", "results_summary": "The abstract does not provide specific findings about Chondroitin's effects but discusses the general importance of GAGs in cellular processes and disease states.", "population_specificity": "Not specified (general discussion of GAGs in animal cells).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:39.659840+00:00"}
{"study_id": 52318, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to establish a placental malaria monkey model to study VAR2CSA-mediated chondroitin sulfate A (CSA) binding and evaluate immunity development.", "results_summary": "The study found that CSA-binding P. falciparum parasites sequestered in placental intervillous spaces, mimicking human placental malaria. Monkeys developed functional antibodies against VAR2CSA after infections or immunization, similar to immune multigravid women.", "population_specificity": "Pregnant Aotus monkeys infected with CSA-binding P. falciparum CS2 parasites during the third trimester.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:39.936750+00:00"}
{"study_id": 52319, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of combining glucosamine and chondroitin for treating knee osteoarthritis.", "results_summary": "The combination of glucosamine and chondroitin showed a statistically significant advantage in reducing WOMAC scores compared to placebo, but no significant differences in VAS scores or most secondary outcomes. Safety analysis indicated no significant differences in adverse effects between treatment groups.", "population_specificity": "Patients with knee osteoarthritis (total n=3793, with 1067 receiving the combination treatment).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:41.770454+00:00"}
{"study_id": 52316, "supplement_id": 1021, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of vestronidase alfa (recombinant human \u03b2-glucuronidase) in reducing urinary glycosaminoglycan (GAG) excretion and improving clinical outcomes in pediatric subjects with MPS VII.", "results_summary": "The study found statistically significant reductions in urinary GAG excretion (-61% at week 48), improved growth velocity, and resolution of hepatosplenomegaly in most subjects. No new safety signals were identified, though mild-to-moderate infusion-associated reactions occurred in 50% of subjects.", "population_specificity": "Pediatric subjects <5 years of age with Mucopolysaccharidosis (MPS) VII.", "effective_dosage": "4 mg/kg every other week by intravenous infusion.", "study_duration": "48 weeks (treatment period), with an optional continuation period of up to 240 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:41.907035+00:00"}
{"study_id": 52323, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the potential application of nutraceuticals, including Chondroitin, in osteoarthritis (OA), focusing on their molecular mechanisms, efficacy, and safety.", "results_summary": "The abstract highlights that nutraceuticals, including Chondroitin, may reduce inflammation, oxidative stress, pain, and joint stiffness while improving cartilage formation, but specific efficacy data for Chondroitin is not detailed.", "population_specificity": "Adults with osteoarthritis (OA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:44.938878+00:00"}
{"study_id": 52320, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of intravesical antimicrobials, including hyaluronic acid with chondroitin sulphate, in managing uncomplicated recurrent urinary tract infections (rUTIs).", "results_summary": "The study found that hyaluronic acid with chondroitin sulphate was effective in reducing UTI frequency, with 10 out of 13 studies showing statistically significant decreases. Dosages of 40 mg and 800 mg per instillation were effective.", "population_specificity": "Mostly women with a mean age range of 27-80 (median: 53.1).", "effective_dosage": "40 mg and 800 mg of hyaluronic acid with chondroitin sulphate per instillation.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:45.009785+00:00"}
{"study_id": 52322, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, pharmacokinetics/pharmacodynamics, and efficacy of odiparcil (which affects chondroitin sulfate levels) in patients with MPS VI.", "results_summary": "Odiparcil increased urine GAGs, including chondroitin sulfate, and showed a good safety profile. Improvements were noted in pain, corneal clouding, and organ functions compared to placebo.", "population_specificity": "Patients aged \u226516 years with MPS VI, some receiving ERT and others not.", "effective_dosage": "250 mg or 500 mg twice daily.", "study_duration": "26 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:45.712829+00:00"}
{"study_id": 52324, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the bioactivities of fucosylated chondroitin sulfates (FCS) from sea cucumber, focusing on their potential therapeutic effects in metabolic syndromes, cancer, HIV infection, and cyclophosphamide side effects.", "results_summary": "FCS demonstrated benefits in preventing metabolic syndromes (e.g., insulin resistance, inflammation, hyperlipidemia, adipogenesis) and showed therapeutic efficacy in cancer, HIV infection, and cyclophosphamide side effects, likely through gut microbiota modulation. Bioactivity varied with molecular weight, sulfation patterns, and chain conformations.", "population_specificity": "Not specified (in vitro or animal studies implied by context).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:48.381904+00:00"}
{"study_id": 52326, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review current knowledge on dietary supplements, including chondroitin, for managing knee osteoarthritis.", "results_summary": "The abstract mentions that results from small studies on natural products like chondroitin for knee OA are encouraging, but more well-designed placebo-controlled trials are needed.", "population_specificity": "Patients with knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:48.499017+00:00"}
{"study_id": 52329, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare guideline recommendations for hip and knee osteoarthritis, including the use of chondroitin sulfate, and assess their level of evidence.", "results_summary": "The study found disagreement among guidelines regarding the use of chondroitin sulfate for osteoarthritis treatment, with varying levels of evidence and conflicting recommendations.", "population_specificity": "Patients with hip or knee osteoarthritis.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:49.533920+00:00"}
{"study_id": 52328, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the pharmacological effects of sulfated fucose-rich polysaccharides, including fucosylated chondroitin sulfate, focusing on their potential as therapeutic agents or functional foods.", "results_summary": "The study highlights various pharmacological effects of sulfated polysaccharides, including antidislipidemic, immunomodulatory, antitumor, hypoglycemic, and hemostatic effects, based on animal models and some human trials.", "population_specificity": "Animal experimental models and some human trials (not specified in detail).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:49.743814+00:00"}
{"study_id": 52331, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the potential of carbohydrate-based microneedles, including chondroitin sulfate, for drug delivery and biomedical applications.", "results_summary": "The abstract summarizes the use of chondroitin sulfate in microneedle fabrication but does not provide specific results on its effects or performance.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:52.648046+00:00"}
{"study_id": 52325, "supplement_id": 1021, "safety_score": "100", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a liquid supplement containing chondroitin, along with hyaluronan and glucosamine, could improve symptoms and quality of life in patients with moderate knee osteoarthritis pain.", "results_summary": "The study found no significant improvement in knee OA pain, symptoms, or quality of life with the supplement compared to placebo, though some SF-36 scores showed numerically higher changes. No treatment-related adverse events were reported.", "population_specificity": "Patients with knee osteoarthritis and moderate knee pain (visual analogue scale of 4-6 points).", "effective_dosage": "250 mg chondroitin, 750 mg glucosamine, and 50 mg hyaluronan in a 20 mL liquid dose, administered once daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:53.340711+00:00"}
{"study_id": 52332, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the association between nutritional supplements, including chondroitin, and chronic pain relief in cancer patients/survivors.", "results_summary": "One study found that chondroitin, combined with glucosamine, improved pain outcomes after 12 and 24 weeks of supplementation in cancer patients. No adverse effects or safety concerns were reported for chondroitin.", "population_specificity": "Patients with breast, gastrointestinal, and gynecological cancers.", "effective_dosage": "Not specified", "study_duration": "12 and 24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:54.231636+00:00"}
{"study_id": 52330, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the use of chondroitin sulfate as a component in dissolving microneedles for transdermal drug delivery.", "results_summary": "The abstract mentions chondroitin sulfate as one of the water-soluble materials used in dissolving microneedles, but no specific results about its effects are provided. The focus is on the broader application and fabrication techniques of microneedles.", "population_specificity": "Not specified (review article, not a clinical study).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:55.337505+00:00"}
{"study_id": 52333, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review recent preclinical and clinical studies on stem cells and supportive therapies, including potential synergistic approaches, for treating chronic spinal cord injury.", "results_summary": "The abstract summarizes ongoing and completed trials involving various stem cell types and molecular therapies combined with scaffolds to address barriers like glial scarring and immunorejection in chronic SCI, but does not specifically mention Chondroitin.", "population_specificity": "Patients with chronic spinal cord injury.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:56.431732+00:00"}
{"study_id": 52334, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the applications of polysaccharide-based nanoparticles, including chondroitin sulfate, in various tumor therapies.", "results_summary": "The abstract highlights the potential of polysaccharide-based nanoparticles, including chondroitin sulfate, for enhancing tumor treatment through chemotherapy, photothermal therapy, photodynamic therapy, gene therapy, and immunotherapy, but does not provide specific results for chondroitin alone.", "population_specificity": "Not specified (general review of polysaccharide-based biomaterials)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:57.599853+00:00"}
{"study_id": 52336, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of chondroitin sulfate (CS) in tissue remodeling and pulmonary fibrotic diseases, and explore its potential as a therapeutic target.", "results_summary": "The abstract suggests that CS participates in tissue remodeling in various diseases, including pulmonary fibrosis, but its biological functions have been less studied compared to other glycosaminoglycans. The review discusses CS's involvement in fibrosis and potential therapeutic approaches targeting it.", "population_specificity": "Not specified (review article, not a clinical study)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:58.142384+00:00"}
{"study_id": 52335, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate how the updated ESCEO algorithm for knee osteoarthritis management, which includes chondroitin sulfate as a key treatment, was perceived and integrated into clinical practice by Chinese experts.", "results_summary": "The study found that chondroitin sulfate, along with crystalline glucosamine sulfate, is supported by high-quality research as an effective symptomatic slow-acting drug for osteoarthritis (SYSADOA) and is considered a key background treatment in step 1 of the algorithm.", "population_specificity": "Chinese experts in knee osteoarthritis management.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:58.153514+00:00"}
{"study_id": 52337, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining whether hypersulfated chondroitin sulfate, among other non-heparin medications, can trigger heparin-induced thrombocytopenia (HIT).", "results_summary": "The abstract mentions that hypersulfated chondroitin sulfate can trigger HIT, similar to heparin, but does not provide specific efficacy or safety data for chondroitin.", "population_specificity": "Not specified (general discussion of HIT triggers, not a specific study population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:00.607306+00:00"}
{"study_id": 52338, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to summarize current literature on the treatment of radiation urethritis and cystitis (RUC), including the use of intravesical hyaluronic acid/chondroitin for generalized bleeding.", "results_summary": "The study found that intravesical installation of hyaluronic acid/chondroitin is indicated for generalized bleeding in RUC, as part of a stepwise treatment approach. No specific efficacy data for chondroitin alone were provided.", "population_specificity": "Patients with radiation-induced urethritis and cystitis (RUC), specifically those with generalized bleeding.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:02.051672+00:00"}
{"study_id": 52340, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the role of glial/fibrotic scar formation in CNS injury and explore potential therapeutic approaches, including scar modulation, to restore function.", "results_summary": "The abstract does not specifically mention Chondroitin or its effects, focusing instead on the broader mechanisms of scar formation and potential treatments for CNS injury.", "population_specificity": "Not specified (abstract discusses CNS injury broadly, including spinal cord injury, stroke, infection, and neurodegenerative diseases).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:03.158400+00:00"}
{"study_id": 52339, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to identify modifiable clinical factors, including the use of chondroitin, associated with radiographic osteoarthritis progression in people with painful medial knee osteoarthritis.", "results_summary": "The study did not find chondroitin to be independently associated with radiographic osteoarthritis progression, though it was adjusted for in the analysis. The primary findings linked NSAID use and lack of physical activity to increased progression risk.", "population_specificity": "Community-dwelling individuals with chronic knee pain (\u22654/10) and mild medial tibiofemoral narrowing (retaining >2mm joint space width), mean age 60 years.", "effective_dosage": "Not specified", "study_duration": "1-2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:03.207577+00:00"}
{"study_id": 52341, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to assess the expression and prognostic value of PDGFA in esophageal squamous cell carcinoma (ESCC) and identify related signaling pathways, including glycosaminoglycan biosynthesis chondroitin sulfate.", "results_summary": "The study found that PDGFA expression was upregulated in ESCC tissues and associated with poorer overall survival. Gene set enrichment analysis identified chondroitin sulfate biosynthesis as one of the pathways enriched in PDGFA high expression phenotype.", "population_specificity": "Patients with esophageal squamous cell carcinoma (ESCC).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:04.713977+00:00"}
{"study_id": 52343, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the long-term efficacy and safety of chondroitin as a DMOAD in adults with knee and hip osteoarthritis.", "results_summary": "Chondroitin minimally improved joint structure (SMD 0.21) and symptoms (pain: -0.06; function: -0.15), with statistically significant but clinically questionable benefits. It had a favorable safety profile.", "population_specificity": "Adults with knee and hip osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "At least 12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:05.702646+00:00"}
{"study_id": 52342, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of extracellular matrix components, including chondroitin sulphate proteoglycans, in multiple sclerosis lesions and their impact on neuroinflammation and remyelination.", "results_summary": "The abstract discusses that chondroitin sulphate proteoglycans are among the extracellular matrix molecules deposited in multiple sclerosis lesions, contributing to an inhibitory microenvironment that impairs oligodendrocyte recruitment and exacerbates inflammation, though specific effects of chondroitin itself are not detailed.", "population_specificity": "Multiple sclerosis lesions (not human subjects directly).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:06.046292+00:00"}
{"study_id": 52344, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of glycosaminoglycans (GAGs), including Chondroitin, in tumorigenesis and their potential as targets or delivery mechanisms for anticancer therapy.", "results_summary": "The study found that GAGs, including Chondroitin, undergo structural changes during cancer progression and have potential as therapeutic targets or drug delivery vehicles due to their physicochemical properties.", "population_specificity": "Not specified (general focus on cancer tissues and tumor microenvironment).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:06.262943+00:00"}
{"study_id": 52345, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the integration of the 2019 ESCEO algorithm, including the use of chondroitin sulfate, into clinical practice for knee osteoarthritis management in Southeast Asian countries.", "results_summary": "The study found that chondroitin sulfate, as part of symptomatic slow-acting drugs for osteoarthritis, has high-quality evidence supporting its use in step 1 of the ESCEO algorithm. It was highlighted as a main background therapy for knee osteoarthritis.", "population_specificity": "Southeast Asian experts and patients with knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:08.927152+00:00"}
{"study_id": 52347, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of biomimetic hydrogels, including those containing chondroitin sulfate, for cartilage regeneration by assessing their mechanical properties and ability to enhance cell function.", "results_summary": "The study summarized various formulations of cartilage-like hydrogels, noting that chondroitin sulfate-based hydrogels showed favorable mechanical properties and enhanced cell viability and glycosaminoglycan (GAG) content, suggesting potential for cartilage repair. However, the abstract does not provide specific quantitative results for chondroitin sulfate alone.", "population_specificity": "Not specified (in vitro or preclinical studies implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:11.319625+00:00"}
{"study_id": 52349, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the roles of specific chondroitin sulfate proteoglycans (CSPGs) in the pathogenesis of neurodegenerative diseases and their potential treatment implications.", "results_summary": "The abstract highlights that CSPGs, including versican, aggrecan, neurocan, and NG2, play important roles in the development, maturation, and pathophysiological response of the nervous system, particularly in neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and multiple sclerosis. Updated reports suggest CSPGs are involved in treating these conditions.", "population_specificity": "The study focuses on the general nervous system and neurodegenerative diseases, without specifying a particular human or animal population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:13.043142+00:00"}
{"study_id": 52353, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the current progress in biomaterials, including chondroitin sulfate, for preventing postoperative peritoneal adhesion (PPA) and discuss challenges in developing better antiadhesion materials.", "results_summary": "The abstract mentions chondroitin sulfate as one of several biomaterials studied for PPA prevention, but no specific results regarding its efficacy or effects are detailed. The focus is on the broader field of antiadhesion materials and animal models.", "population_specificity": "Not specified (general review of biomaterials and animal models).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:14.451219+00:00"}
{"study_id": 52351, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of an oral low molecular weight liquid hyaluronic acid supplement on knee osteoarthritis symptoms in patients with mild knee pain.", "results_summary": "The study found significant reductions in WOMAC pain, stiffness, and physical function scores, as well as improvements in SF-36 physical functioning and bodily pain domains in the treatment group compared to placebo. The differences between groups were statistically significant for WOMAC scores but not for the SF-36 total score.", "population_specificity": "Knee osteoarthritis patients with mild knee pain (VAS \u2264 3) in Taiwan.", "effective_dosage": "20 mL daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:14.493824+00:00"}
{"study_id": 52348, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether GCM supplementation (including chondroitin) provided additional clinical benefits compared to arthrocentesis plus intraarticular HA injection alone in patients with TMJ-OA.", "results_summary": "The study found no statistically significant differences in clinical outcomes between the group receiving GCM supplementation and the control group, suggesting no additional benefits from GCM. Both groups showed improvements in pain, joint sounds, masticatory efficiency, and lateral mandibular motion, but these changes were not significantly different between groups.", "population_specificity": "Adult patients with TMJ-OA (temporomandibular joint osteoarthritis).", "effective_dosage": "Not specified (only mentioned as 3 months of GCM supplementation).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:14.553271+00:00"}
{"study_id": 52352, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy and safety of a new fixed-dose combination of glucosamine sulfate and bovine chondroitin sulfate versus a reference product in treating knee osteoarthritis symptoms.", "results_summary": "The new GS/CS formulation was non-inferior to the reference product in reducing WOMAC pain scores, with high responder rates (89.4% vs. 87.9%) and improvements in stiffness, physical function, and overall OA assessment. Headache and glucose tolerance changes were the most frequent adverse events.", "population_specificity": "Patients with knee osteoarthritis (Kellgren-Lawrence grades 2 or 3) and mean WOMAC pain subscale score \u226540 mm.", "effective_dosage": "1200 mg bovine chondroitin sulfate daily (fixed-dose combination with 1500 mg glucosamine sulfate).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:17.006912+00:00"}
{"study_id": 52354, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the use of polysaccharides and polypeptide-based biomaterials, including chondroitin sulfate, in the fabrication of biodegradable microneedles for transdermal drug delivery.", "results_summary": "The abstract highlights chondroitin sulfate as one of the complex carbohydrate polymers used in biodegradable microneedles, emphasizing its advantages such as biodegradability, biocompatibility, and ease of fabrication, but does not provide specific results on its effects.", "population_specificity": "Not specified (review of biomaterials for transdermal drug delivery)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:17.381895+00:00"}
{"study_id": 52355, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the role of glycosaminoglycans, including Chondroitin, in tissue engineering and evaluate recent advances in their use for driving stem cell fate and promoting cell proliferation.", "results_summary": "The abstract highlights that glycosaminoglycans, such as Chondroitin, are promising for tissue engineering due to their ability to mimic the extracellular matrix, drive stem cell behavior, and promote cell proliferation in engineered tissues. The review also discusses recent advances and future directions in this research niche.", "population_specificity": "Not specified (general focus on tissue engineering applications)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:20.470547+00:00"}
{"study_id": 52357, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to explore factors, including chondroitin sulfate proteoglycans, that inhibit axonal regeneration in the central nervous system after injury.", "results_summary": "The study identified chondroitin sulfate proteoglycans as inhibitors of axonal regeneration by activating RhoA signaling, leading to growth cone collapse. It contrasts these inhibitory mechanisms with molecules that promote regeneration.", "population_specificity": "Animal models (e.g., spinal cord injury, optic nerve injury)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:20.850828+00:00"}
{"study_id": 52360, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the potential of chondroitin sulfate (CS)-based nanoparticles for targeted drug delivery in various cancer therapies.", "results_summary": "The study found that CS-based nanoparticles, including conjugates, polymer NPs, and nanogels, show promise for targeted drug delivery in tumor chemotherapy, gene therapy, and other cancer treatments due to their biocompatibility and CD44 targeting ability.", "population_specificity": "Not specified (review of preclinical and potential clinical applications).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:22.836970+00:00"}
{"study_id": 52358, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of an oral preparation containing chondroitin sulfate (CS) combined with other compounds on clinical and synovial fluid markers in patients with knee osteoarthritis (OA).", "results_summary": "The treated group showed significant improvements in clinical indices (WOMAC, Lequesne, VAS pain) and reductions in inflammatory cytokines (IL-8, IL-6, IL-10) in synovial fluid, while the control group showed no significant changes.", "population_specificity": "Thirty patients with knee OA and swollen joints.", "effective_dosage": "240 mg CS once daily (combined with 120 mg HA and 300 mg K).", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:23.423981+00:00"}
{"study_id": 52359, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of a low-dose curcumagalactomannosides (CGM) supplement against a standard combination of glucosamine hydrochloride and chondroitin sulphate in alleviating osteoarthritis (OA) symptoms.", "results_summary": "The study found that CGM showed significant improvements in VAS, KPS, walking performance, and WOMAC scores compared to baseline, outperforming the chondroitin-glucosamine combination. CGM also reduced serum inflammatory markers, suggesting superior short-term benefits for OA symptom relief.", "population_specificity": "72 OA subjects who completed the 6-week trial out of 84 initially randomized.", "effective_dosage": "415 mg chondroitin sulphate combined with 500 mg glucosamine hydrochloride, taken twice daily.", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:24.508799+00:00"}
{"study_id": 52361, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers compared the recommendations of OARSI and ESCEO guidelines regarding the use of chondroitin sulfate in the non-surgical management of knee osteoarthritis.", "results_summary": "ESCEO recommends pharmaceutical-grade chondroitin sulfate for knee osteoarthritis, while OARSI strongly recommends against its use, including all chondroitin formulations. The guidelines differ on chondroitin but agree on most other treatment recommendations.", "population_specificity": "Individuals with knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:24.634881+00:00"}
{"study_id": 52362, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 74, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of prescription-grade chondroitin sulfate (pCS) on pain and physical function in patients with knee osteoarthritis.", "results_summary": "The study found that pCS significantly reduced pain (SMD -0.26) in knee OA patients, though its effect on physical function was not explicitly mentioned in the abstract.", "population_specificity": "Patients suffering from knee osteoarthritis (15,609 individuals for pain outcomes, 13,655 for function outcomes).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:25.415838+00:00"}
{"study_id": 52363, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the potential of marine-derived molecules, including sulfated polysaccharides like Chondroitin, as alternative antithrombotic agents with minimal bleeding risks.", "results_summary": "The abstract highlights that marine antithrombotics, particularly sulfated polysaccharides, show promise due to unique mechanisms of action and reduced bleeding risks, but further clinical studies are needed.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:29.314181+00:00"}
{"study_id": 52364, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the potential of Chondroitin sulfate (CS) in preventing necrotizing enterocolitis (NEC) by examining its anti-inflammatory properties and effects on the infant microbiome.", "results_summary": "The abstract suggests CS may help prevent NEC due to its anti-inflammatory properties and protective effects on the gut microbiome, potentially mitigating breast milk disparities when added to formula. However, no direct experimental results or clinical outcomes are provided.", "population_specificity": "High-risk infants, particularly preterm neonates in NICUs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:29.584783+00:00"}
{"study_id": 52365, "supplement_id": 1021, "safety_score": "79", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of various intravesical agents, including chondroitin sulphate, for treating interstitial cystitis/bladder pain syndrome (IC/BPS).", "results_summary": "Chondroitin sulphate ranked second in ICSI improvement, third in ICPI improvement, and first in VAS scores among the studied agents. It was also found to be safer than other agents, with a 78.5% probability of fewer complications.", "population_specificity": "Patients with interstitial cystitis/bladder pain syndrome (IC/BPS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:31.434323+00:00"}
{"study_id": 52367, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of CSPG4 in the tumor microenvironment of human gliomas and its potential as a therapeutic target.", "results_summary": "The study found that CSPG4 plays a key role in tumor growth and invasion by driving oncogenic pathways and promoting interactions in the tumor microenvironment, suggesting its potential as a biomarker and therapeutic target.", "population_specificity": "Human gliomas (brain tumors)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:31.964539+00:00"}
{"study_id": 52366, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the role of brain-enriched hyaluronan binding (BEHAB)/brevican (B/b) in the glioma tumor microenvironment and explore its potential as a therapeutic target.", "results_summary": "The study found that B/b is highly overexpressed in gliomas and contributes to tumor invasiveness and aggressiveness, suggesting it as a potential target for therapy. The complexity of B/b, including its splice variants and glycoforms, provides unique opportunities for therapeutic intervention.", "population_specificity": "Patients with malignant gliomas (central nervous system tumors).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:32.735665+00:00"}
{"study_id": 52368, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to provide an overview of glycosaminoglycan (GAG)-protein interactions, including chondroitin sulfate, and to draft a comprehensive GAG interactome.", "results_summary": "The study identified 832 biomolecules (827 proteins and five GAGs) and 932 protein-GAG interactions, highlighting the role of GAGs in various physiological and pathological contexts, but did not specifically report on chondroitin's effects.", "population_specificity": "Not specified (broad focus on mammalian glycosaminoglycans)", "effective_dosage": "Not available", "study_duration": "Not applicable (review and network analysis)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:33.313364+00:00"}
{"study_id": 52369, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of chondroitin sulfate as part of a stepwise pharmacological management approach for osteoarthritis.", "results_summary": "The study found that chondroitin sulfate is recommended as a background maintenance therapy for osteoarthritis, with high-quality evidence supporting its efficacy, particularly when used alongside other treatments like NSAIDs or intra-articular injections.", "population_specificity": "Patients with osteoarthritis, specifically knee OA, in the context of Russian clinical practice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:33.381934+00:00"}
{"study_id": 52350, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to compare the clinical efficacy and safety of pharmacological interventions, including chondroitin sulfate, for interstitial cystitis and bladder pain syndrome (IC/BPS).", "results_summary": "Chondroitin sulfate showed no significant difference in safety outcomes compared to other treatments, with urinary symptoms being the only variate where botulinum toxin A had a higher incidence rate than chondroitin sulfate. The study did not highlight significant efficacy outcomes for chondroitin sulfate in reducing IC/BPS symptoms.", "population_specificity": "Participants with interstitial cystitis and bladder pain syndrome (IC/BPS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:36.539285+00:00"}
{"study_id": 52372, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the diverse biological and pathological roles of the I\u03b1I family, including its interaction with chondroitin sulfate, and explore its clinical applications in inflammatory conditions.", "results_summary": "The study highlights the I\u03b1I family's matrix protective activity, interactions with extracellular molecules like hyaluronan, and roles in tissue homeostasis. It also discusses clinical uses in treating inflammatory conditions such as sepsis and Kawasaki disease.", "population_specificity": "Not specified (broad review of vertebrate evolution and clinical applications)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:37.808580+00:00"}
{"study_id": 52370, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the symptomatic effects of a 14-day treatment with GERDOFF\u00ae (containing chondroitin sulphate) in GERD patients, particularly its efficacy in reducing GER-related symptoms.", "results_summary": "The study found that GERDOFF\u00ae significantly reduced heartburn episodes and GERD-related symptoms over 14 days, with improvements seen in both patients on and off PPI therapy. The treatment was safe, well-tolerated, and highly rated for patient satisfaction.", "population_specificity": "GERD patients, including those on stable PPI therapy and those not responding to PPI or alginate-based formulations.", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:38.492493+00:00"}
{"study_id": 52374, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effect of chondroitin sulphate on the properties of electrospun gelatin nanofibres for antimicrobial wound dressings and tissue regeneration.", "results_summary": "Chondroitin sulphate improved the mechanical properties, wettability, and biocompatibility of nanofibres, which enhanced wound closure, re-epithelialization, and collagen organization in a porcine burn model compared to untreated burns.", "population_specificity": "Porcine model of cutaneous burn injury.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:40.081210+00:00"}
{"study_id": 52377, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 63, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness of chondroitin in providing meaningful pain relief for patients with chronic osteoarthritis compared to control treatments.", "results_summary": "The study found that chondroitin had a statistically significant but modest effect on pain relief (RR = 1.26; 95% CI 1.13 to 1.41). However, subgroup analysis showed no effect in studies that were only publicly funded.", "population_specificity": "Patients with chronic osteoarthritis pain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:41.442538+00:00"}
{"study_id": 52375, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review various methods for detecting and analyzing glycosaminoglycans (GAGs), including Chondroitin, to diagnose and monitor Mucopolysaccharidoses (MPS).", "results_summary": "The study reviewed multiple qualitative and quantitative methods for GAG detection, concluding that LC-MS/MS is a rapid, sensitive, specific, and cost-effective method for GAG analysis in biological systems.", "population_specificity": "Not specified (focus on methodological review, not a clinical population).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:41.443833+00:00"}
{"study_id": 52381, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specifically address the researchers' goals regarding Chondroitin.", "results_summary": "The abstract mentions Chondroitin as a dietary supplement used in conservative treatment modalities for degenerative disc disease but does not provide specific findings about its effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:45.480961+00:00"}
{"study_id": 52376, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate oncofetal chondroitin sulfate as a potential therapeutic target in solid tumors, particularly childhood cancers, based on its differential overexpression in tumors compared to healthy tissues.", "results_summary": "The study highlights oncofetal chondroitin sulfate as a cancer-specific glycosaminoglycan modification, overexpressed in solid tumors and metastasis but normally exclusive to the placenta, suggesting its potential as a broad and specific therapeutic target. Current investigations focus on leveraging this biology for targeted interventions in adult and childhood cancers.", "population_specificity": "Solid tumors and metastasis, with specific mention of childhood solid tumors.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:45.502109+00:00"}
{"study_id": 52379, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review current diagnosis, treatment, and management strategies for MPS IVA, including the role of chondroitin-6-sulfate accumulation in the disease.", "results_summary": "The abstract highlights that chondroitin-6-sulfate accumulates in MPS IVA patients due to enzyme deficiency, contributing to skeletal dysplasia, but does not evaluate its efficacy or safety as a supplement. Current therapies like ERT and HSCT have limited impact on bone and cartilage lesions.", "population_specificity": "Patients with Mucopolysaccharidosis type IVA (MPS IVA, or Morquio syndrome type A).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:45.840872+00:00"}
{"study_id": 52380, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of chondroitin sulfate (CS) nanocarriers as effective and safe drug delivery vehicles for cancer therapy, focusing on their biocompatibility, targeting capabilities, and therapeutic applications.", "results_summary": "The study found that CS-based nanocarriers exhibit low toxicity, biocompatibility, and effective active and passive tumor targeting, making them promising for cancer therapy. CS nanocarriers were also implicated in immunotherapy, radiotherapy, and other cancer treatments.", "population_specificity": "Not specified (focused on in vitro or preclinical applications).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:46.327555+00:00"}
{"study_id": 52384, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of chondroitin sulfate for managing osteoarthritis, specifically hand OA, as part of a broader guideline update.", "results_summary": "The study made a conditional recommendation for chondroitin sulfate in hand OA, indicating modest but not definitive evidence of efficacy. No strong recommendation was made, suggesting mixed or limited clinical benefits.", "population_specificity": "Patients with hand osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:48.613233+00:00"}
